0001214659-16-011450.txt : 20160511 0001214659-16-011450.hdr.sgml : 20160511 20160511164430 ACCESSION NUMBER: 0001214659-16-011450 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160511 DATE AS OF CHANGE: 20160511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wright Investors Service Holdings, Inc. CENTRAL INDEX KEY: 0001279715 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 134005439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50587 FILM NUMBER: 161640449 BUSINESS ADDRESS: STREET 1: 100 SOUTH BEDFORD ROAD, SUITE 2R CITY: MOUNT KISCO STATE: NY ZIP: 10549 BUSINESS PHONE: (914) 242-5700 MAIL ADDRESS: STREET 1: 100 SOUTH BEDFORD ROAD, SUITE 2R CITY: MOUNT KISCO STATE: NY ZIP: 10549 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL PATENT DEVELOPMENT CORP DATE OF NAME CHANGE: 20040211 10-Q 1 d5616010q.htm FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2016 d5616010q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q
(Mark One)

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the quarterly period ended March 31, 2016
   
or
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the transition period from _____ to _____

Commission File Number: 000-50587

WRIGHT INVESTORS’ SERVICE HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware
 
13-4005439
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

177 West Putnam Avenue, Greenwich, CT
06830
(Address of principal executive offices)
(Zip code)

(914) 242-5700
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x No  o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x  No  o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
 
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
(Do not check if a smaller reporting company)
o
Smaller reporting company
 
x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o    No  x   
 
As of May 11, 2016, there were 18,919,573 shares of the registrant’s common stock, $0.01 par value, outstanding.
 


 
 

 
 
WRIGHT INVESTORS’ SERVICE HOLDINGS, INC.

TABLE OF CONTENTS
 
 
 
Part I.  Financial Information
Page No.
     
1
     
   
 
1
     
   
 
2
     
   
 
3
     
   
 
4
     
   
 
5
     
     
     
 
 
13
     
16
     
16
 
 
Part II. Other Information
 
 
17
     
18
   
19
 
 
 

 
 
PART I. FINANCIAL INFORMATION
 
 
WRIGHT INVESTORS' SERVICE HOLDINGS, INC.
(unaudited)
(in thousands, except per share amounts)

   
Three Months Ended March 31,
 
   
2016
   
2015
 
Revenues
           
Investment management services
  $ 588     $ 623  
Other investment advisory services
    714       697  
Financial research and related data
    175       158  
      1,477       1,478  
Expenses
               
Compensation and benefits
    1,092       1,295  
Other operating
    904       1,082  
      1,996       2,377  
                 
Operating loss
    (519 )     (899 )
                 
Interest expense and other income (loss),  net
    28       (37 )
                 
Change in fair value of contingent consideration
    -       112  
                 
Loss before income taxes
    (491 )     (824 )
                 
Income tax expense
    (16 )     (17 )
Net loss
  $ (507 )   $ (841 )
                 
Basic and diluted net loss per share
  $ (0.03 )   $ (0.04 )
 
See accompanying notes to condensed consolidated financial statements.
 
 
1

 
 
WRIGHT INVESTORS' SERVICE HOLDINGS, INC.
(in thousands, except per share amounts)

   
March 31,
   
December 31,
 
   
2016
   
2015
 
Assets
 
(unaudited)
       
Current assets
           
Cash and cash equivalents
  $ 8,227     $ 8,493  
Short-term investments
    -       157  
Accounts receivable,net
    359       326  
Prepaid income taxes
    8       37  
Prepaid expenses and other current assets
    373       456  
                 
Total current assets
    8,967       9,469  
                 
Property and equipment, net
    44       44  
Intangible assets, net
    2,485       2,644  
Goodwill
    3,364       3,364  
Investment in LLC
    321       287  
Investment in undeveloped land
    355       355  
Other assets
    122       120  
Total assets
  $ 15,658     $ 16,283  
                 
Liabilities and stockholders’ equity
               
Current liabilities
               
Accounts payable and accrued expenses
  $ 874     $ 1,030  
Deferred revenue
    14       -  
Current portion of officers retirement bonus liability
    200       200  
Total current liabilities
    1,088       1,230  
                 
Officers retirement bonus liability, net of current portion
    684       714  
Total liabilities
    1,772       1,944  
                 
Stockholders’ equity
               
Common stock
    197       197  
                 
Additional paid-in capital
    33,542       33,488  
                 
Accumulated deficit
    (18,494 )     (17,987 )
                 
Treasury stock, at cost (565,219 common shares at March 31, 2016 and December 31, 2015)
    (1,359 )     (1,359 )
Total stockholders' equity
    13,886       14,339  
Total liabilities and stockholders’ equity
  $ 15,658     $ 16,283  
 
See accompanying notes to condensed consolidated financial statements.
 
 
2

 
 
WRIGHT INVESTORS' SERVICE HOLDINGS, INC.
(unaudited)
(in thousands)
 
   
Three Months Ended March 31,
 
   
2016
   
2015
 
Cash flows from operating activities
           
             
Net loss
  $ (507 )   $ (841 )
Adjustments to reconcile net loss to cash used in operating activities:
               
Realized loss on sale of short-term investments
    9       -  
Depreciation and amortization
    163       164  
Change in liability for contingent consideration
    -       (112 )
Increase in value of warrant
    (2 )     -  
Equity based compensation, including issuance of stock to directors
    54       72  
Equity income in LLC
    (34 )     -  
Changes in other operating items, net :
               
Accounts  receivable
    (33 )     (102 )
Short-term investments
    -       (3 )
Deferred revenue
    14       1  
Officers retirement bonus liability
    (30 )     19  
Prepaid income tax
    29       4  
Prepaid expenses and other current assets
    83       122  
Accounts payable and accrued expenses
    (156 )     72  
Net cash used in operating activities
    (410 )     (604 )
                 
Cash flows from investing activities
               
Proceeds from sale of short-term investments
    148       -  
Additions to property and equipment
    (4 )     (9 )
Net cash  provided by (used in) investing activities
    144       (9 )
                 
Net decrease  in cash and cash equivalents
    (266 )     (613 )
Cash and cash equivalents at the beginning of the period
    8,493       11,163  
Cash and cash equivalents at the end of the period
  $ 8,227     $ 10,550  
                 
Supplemental disclosures of cash flow information
               
Net cash paid during the period for
               
income taxes
  $ -     $ 10  

See accompanying notes to condensed consolidated financial statements.
 
 
3

 
 
WRIGHT INVESTORS' SERVICE HOLDINGS, INC.
THREE MONTHS ENDED MARCH 31, 2016
(UNAUDITED)

                                 
Total
 
               
Additional
         
Treasury
   
stock-
 
   
Common stock
   
paid -in
   
Accumulated
   
stock , at
   
holders
 
   
shares
   
amount
   
capital
   
deficit
   
cost
   
equity
 
                                     
Balance at December 31, 2015
    19,720,971     $ 197     $ 33,488     $ (17,987 )   $ (1,359 )   $ 14,339  
Net loss
    -       -       -       (507 )     -       (507 )
Equity based compensation expense
    -       -       27       -       -       27  
Issuance of common stock to directors
    13,821       -       27       -       -       27  
                                                 
Balance at March 31, 2016
    19,734,792     $ 197     $ 33,542     $ (18,494 )   $ (1,359 )   $ 13,886  

See accompanying notes to condensed consolidated financial statements.
 
 
4

 
 
WRIGHT INVESTORS’ SERVICE HOLDINGS, INC.
 
 
Three months ended March 31, 2016 and 2015
 
(unaudited)
 
1.
Basis of presentation and description of activities
 
 Basis of presentation
 
The accompanying interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  The information and note disclosures normally included in complete financial statements have been condensed or omitted pursuant to such rules and regulations.  The Condensed Consolidated Balance Sheet as of December 31, 2015 has been derived from audited financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2015 as presented in our Annual Report on Form 10-K. In the opinion of management, this interim information includes all material adjustments, which are of a normal and recurring nature, necessary for a fair presentation. The results for the 2016 interim period are not necessarily indicative of results to be expected for the entire year.

 Description of activities
 
On December 19, 2012 (the “Closing Date”), National Patent Development Corporation, which changed its name on February 4, 2013 to Wright Investors’ Service Holdings, Inc. (hereinafter referred to as the “Company” or “Wright Holdings”), completed the acquisition of The Winthrop Corporation, a Connecticut corporation (“Winthrop”) pursuant to that certain  Agreement and Plan of Merger (the “Merger Agreement”) dated June 18, 2012. Winthrop, through its wholly-owned subsidiaries Wright Investors’ Service, Inc. (“Wright”), Wright Investors’ Service Distributors, Inc. (“WISDI”) and Wright’s wholly-owned subsidiary, Wright Private Asset Management, LLC (“WPAM”) (collectively, the “Wright Companies”), offers investment management services,  financial advisory services and investment research to large and small investors, both taxable and tax exempt.  WISDI is a registered broker dealer with the Financial Industry Regulatory Authority, Inc. (“FINRA”) and the Securities and Exchange Commission.  In accordance with the Merger Agreement, a wholly-owned newly formed subsidiary of the Company, was merged with and into Winthrop and Winthrop became a wholly-owned subsidiary of the Company.

Critical accounting policies and estimates
 
There have been no changes to our critical accounting policies and estimates in the three months ended March 31, 2016. The Securities and Exchange Commission (“SEC”) defines “critical accounting policies” as those that require application of management’s most difficult subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Our significant accounting policies are described under “Critical Accounting Policies” in our “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7, as well as in our consolidated financial statements and footnotes thereto for the year ended December 31, 2015, as filed with the Commission with our Annual Report form 10-K filed on March 23, 2016.

Reclassification

The Company has reclassified $11,000 of Compensation and benefits for the period ended March 31, 2015 to Other operating expenses in order to be consistent with the presentation for the period ended March 31, 2016.


2.
Contingent Consideration

In connection with the Company’s acquisition of Winthrop on December 19, 2012, the Company had agreed to pay contingent consideration in cash to a holder of Winthrop common stock who received 852,228 shares of Company Common Stock to the extent that such shares have a value of less than $1,900,000 on the expiration of the three year period based on the average closing price of the Company’s Common Stock for the ten trading days prior to such date.  A liability was recognized for an estimate of the acquisition date fair value of the acquisition-related contingent consideration which may be paid.   Changes in the fair value of the contingent consideration subsequent to the acquisition date were recognized in earnings until the liability was eliminated or settled. In December 2015, the Company paid $236,000 to settle the contingent consideration liability and recognized income of $336,000 for the reduction in the fair value of the liability during the year ended December 31, 2015. The Company recognized income of $112,000 for the change in the fair value of the liability for the three months ended March 31, 2015.
 
 
5

 
 
3. 
Per share data

Loss per share for the three months ended March 31, 2016 and 2015, respectively, is calculated based on 19,198,000 and 19,229,000 weighted average outstanding shares of common stock.  Included in these shares are vested RSUs of 35,706 and 608,526 for the quarters ended March 31, 2016 and 2015, respectively.

Options for 3,375,000 shares of common stock for the three months ended March 31, 2016 and 2015,  and unvested RSUs for 133,332 and 332,923 shares of common stock, respectively, for the three months  ended March 31, 2016 and 2015 were not included in the diluted computation as their effect would be anti-dilutive since the Company incurred net losses for both periods.
 
4. 
Capital Stock 
 
The Company’s Board of Directors, without any vote or action by the holders of common stock, is authorized to issue preferred stock from time to time in one or more series and to determine the number of shares and to fix the powers, designations, preferences and relative, participating, optional or other special rights of any series of preferred stock.
 
The Board of Directors authorized the Company to repurchase up to 5,000,000 outstanding shares of common stock from time to time either in open market or privately negotiated transactions. At March 31, 2016, the Company had repurchased 1,791,971 shares of its common stock and a total of 3,208,029 shares, remained available for repurchase at March 31, 2016.


5.
Short-term investments

Short-term investments, which at December 31, 2015 consisted of mutual funds managed by a subsidiary of Winthrop are stated at the net asset value of the funds and are accounted for as trading securities with unrealized gain or loss included in Interest expense and other income (loss), net in the Condensed Consolidated Statements of Operations.  The Company liquidated these investments in the first quarter of 2016 for proceeds of $148,000 and realized a loss of $9,000.   Unrealized   gains on short term investments amounted to $3,000 during the three months ended March 31, 2015.

6.
Investment in LLC

The Company entered into a Limited Liability Company Agreement dated April 28, 2015 by and among EGS, LLC,  a newly formed Delaware limited liability company (“EGS”) and the members named therein.  The Company invested $333,333 and acquired 333,333 Units, representing a 33.33% Membership Interest in EGS. In addition to the Company, EGS has two other members, one of whom is Marshall Geller, a member of the Company’s Board of Directors. The EGS transaction, as well as Mr. Geller’s participation in the transaction, received the prior approval of the Company’s Audit Committee.  Mr. Geller is the Managing Member of the LLC and also invested $333,333 and acquired 333,333 Units, representing a 33.33% Membership Interest in EGS.
 
EGS entered into a Note Purchase Agreement effective April 28, 2015 with Merriman Holdings, Inc. (“Merriman”), a publically traded company,  pursuant to which EGS purchased from Merriman for an aggregate purchase price of $1,000,000  (i) a one-year  Senior Secured Note in the original principal amount of $1,000,000, at 12% interest, payable quarterly, in arrears (the “Note”) and (ii) a Common Stock Purchase Warrant which expires in five years to purchase 500,000 shares of Merriman common stock  at $1.00 per share (the “Warrants”).   EGS distributed the Warrants to its members and the Company received 166,666 Warrants which expire in five years.  On July 20, 2015, a fourth member joined EGS and invested $333,333, and received a 25% Membership Interest in EGS.  EGS advanced the funds to Merriman and increased its investment in the Note and in addition, received 166,666 additional Warrants which it distributed to its new member.  This transaction reduced the Company’s interest in EGS to 25%, changed the expiration date of the Note to July 20, 2016, and extended the exercise date of the warrant to five years from that date. The investment in EGS is being accounted for under the equity method. Under this method, the Company records its share of EGS’s earnings (losses) in the statement of operations with equivalent amount of increases (decreases) to the investment. The Company recorded approximately $34,000 as its share of EGS’s net income for the quarter ended March 31, 2016, which is included in Interest expense and other income (loss), net.  At April 28, 2015, the Company valued the Warrants at their fair value, of $120,000, using the Black Scholes model, and recorded their value as a reduction in the investment in EGS.   At March 31, 2016 and December 31, 2015, the carrying value of the investment in EGS was $321,000 and $287,000, respectively. The Warrant which permits a cashless exercise, qualifies as a derivative, and is recorded at fair value (based on observable inputs) with change in such value included in earnings.   At March 31, 2016 and December 31, 2015, the value of the Warrant (a Level 2 Security) was $14,000 and $12,000, respectively, which is included in Other Assets in the Consolidated Balance Sheet.  The increase in the value of the Warrant of $2,000  for the quarter ended March 31, 2016 is included in Interest expense and other income (loss), net in the Consolidated Statement of Operations.  Such increase reflects the increase in the price of Merriman’s common stock as measured for the three months ended March 31, 2016.

 
6

 

Merriman is a financial services holding company that provides capital markets advisory and research, corporate and investment banking services through its wholly-owned principal operating subsidiary, Merriman Capital, Inc. (“MC”).  The Note is secured by 99.998% of the capital stock of MC.  Marshall Geller also received 166,666 Warrants with an exercise price of $1.00 per share that expire in five years.
 
The Note, pursuant to the terms of an Intercreditor Agreement entered into with Merriman’s current debt holders, is senior to all of Merriman’s debt.


 
7.
Incentive stock plans and stock based compensation
 
Common stock options

The Company had initially adopted a stock-based compensation plan for employees and non-employee members of its Board of Directors in November 2003 (the “2003 Plan”), which was subsequently amended in March 2007 (the “2003 Plan Amendment”).  In December 2007, the Company adopted the National Patent Development Corporation 2007 Incentive Stock Plan (the “2007 NPDC Plan”).  The plans provide for up to 3,500,000 and 7,500,000 awards for shares under the 2003 Plan Amendment and 2007 NPDC Plan, respectively, in the form of discretionary grants of stock options, restricted stock shares, restricted stock units (RSUs) and other stock-based awards to employees, directors and outside service providers. The Company’s plans are administered by the Compensation Committee of the Board of Directors, which consists solely of non-employee directors. The term of any option granted under the plans will not exceed ten years from the date of grant and, in the case of incentive stock options granted to a 10% or greater holder of total voting stock of the Company, three years from the date of grant.  The exercise price of any option granted under the plans may not be less than the fair market value of the common stock on the date of grant or, in the case of incentive stock options granted to a 10% or greater holder of total voting stock, 110% of such fair market value.

The Company recorded no compensation expense related to option grants for the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, the number of shares reserved and available for award under the 2007 NPDC Plan is 6,116,786 and under the 2003 Plan Amendment is 700,000.

During the three months ended March 31, 2016, the Company issued 100,000 options to a consultant on March 28, 2016 and 25,000 options to an employee on March 31, 2016.  The options issued on March 28, 2016 vest equally over 3 years, and are subject to post vesting restrictions for sale for three years. The options issued on March 31, 2016 vest on the third anniversary of their issuance.  The options were issued at an exercise price of $1.29 and $1.34 per share for the options issued on March 28, 2016 and March 31, 2016, respectively, equal to market value at the date of the grant.  The grant-date fair value of the options were $0.50 and $0.52, respectively, which was estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions:
 
 
Dividend yield
   
0
%
Expected volatility
   
48.24
%
Risk-free interest rate
   
1.21
%
Expected life (in years)
   
4
 

 
The fair value of the options granted on March 28, 2016 were reduced by an 8% discount.

During the three months ended March 31, 2015, there was no option activity.  As of March 31, 2016, there were outstanding options to acquire 3,375,000 common shares, 3,250,000 of which were vested and exercisable, having a weighted average exercise price of $2.27 per share, a weighted average contractual term of 1.7 years and an aggregate intrinsic value of $5,000.

As of March 31, 2016, the unrecognized compensation expense related to non-vested options was $59,000. 


Restricted stock units

As a result of the Winthrop acquisition, the Company issued a total of 849,280 RSUs on the closing date to be settled in shares of Company common stock as follows:

 
a)
479,280 RSUs were granted to four key executives of Winthrop, which vested as of the Closing Date and are subject to post-vesting restrictions on sale for three years.  The RSUs were valued at the closing price of the Company’s common stock of $2.52, less a 20% discount for post vesting restrictions on sale, or $2.02 per share.  The total value of these RSUs of $966,000, were accounted for as compensation and charged to retention bonus expense on the closing date.
 
 
7

 
 
 
b)
370,000 RSUs were granted to four key executives, which vest  equally over three years, with the first third vesting one year from the Closing Date.  The RSUs were valued based on the closing price of the Company’s common stock on the Closing Date of $2.52, less an average discount of 11% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $2.25. The Company recorded compensation expense of $69,000 for the quarter ended March 31, 2015 related to these RSUs.

 
At December 19, 2015, the above RSUs were fully vested.    In December 2015, the Company repurchased 252,767 RSUs for a total cost of $369,000.  The remaining 596,513 RSUs were settled by the issuance of 596,513 common shares in the first quarter of 2016. Such issuable shares are included in the outstanding common shares at December 31, 2015 in the accompanying financial statements.


In addition, the following RSUs were granted to employees of the Company:
 
 
(c)
17,738 RSUs were granted to certain employees on February 4, 2013, which vest equally over three years, with the first third vesting on February 4, 2014.  At March 31, 2016, 11,701 of the RSU’s were fully vested.  The RSUs are valued based on the closing price of the Company’s common stock on February 4, 2013 of $2.40, less an average discount of 11% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $2.25.  The Company recorded compensation expense of $1,000 and $3,000, respectively, for the quarters ended March 31, 2016 and 2015 related to these RSUs.   There was no unrecognized compensation expense related to these unvested RSUs at March 31, 2016.

 
d)
30,000 RSUs were granted to an employee on June 10, 2014, which will vest on the third anniversary of the individual’s employment, assuming the individual is still employed at that time.   The RSUs are valued based on the closing price of the Company’s common stock on June 10, 2014 of $1.90.   For the quarter ended March 31, 2015,  $11,000 of compensation expense previously recorded during the year ended December 31, 2014 related to these RSUs was reversed since in the first quarter of 2015, the individual was no longer employed by the Company and the above RSUs were cancelled. 
 
 
e)
On January 19, 2015 and March 31, 2015, 100,000 RSUs were issued on each date to two newly appointed directors of the Company.  The RSUs will vest equally over 3 years.  The RSUs are valued based on the closing price of the Company’s common stock on January 19, 2015 and March 31, 2015 of $1.70 and $1.85, respectively, less an average discount of 8% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $1.56 and $1.70, respectively.  The Company recorded compensation expense of $26,000 and $11,000 for the quarters ended March 31, 2016 and 2015, respectively,  related to these RSUs.  The total unrecognized compensation expense related to these unvested RSUs at March 31, 2016 is $205,000, which will be recognized over the remaining vesting period of approximately 2 years.
 
 
8

 
 
8. 
Intangible Assets
 
At March 31, 2016, intangible assets subject to amortization which were recorded in connection with the acquisition of Winthrop consisted of the following (in thousands):


 
Intangible
Estimated
useful life
 
Gross
carrying
amount
   
Accumulated
Amortization
   
Net
carrying
amount
 
                     
Investment management and Advisory Contracts
  9 years
 
$
3,181
   
$
1,159
   
$
2,022
 
Trademarks
   10 years
   
 433
     
142
     
291
 
Proprietary software and
technology
   
4 years
   
   960
     
788
     
  172
 
     
$
4,574
   
$
2,089
   
$
2,485
 


For the three month periods ended March 31, 2016 and 2015, amortization expense was $159,000 and $160,000, respectively. The weighted-average amortization period for total amortizable intangibles at March 31, 2016 is 4.75 years.  Estimated amortization expense for each of the five succeeding years and thereafter is as follows (in thousands):


Year ending December 31,
 
 
2016 (remainder)
 
$470
2017
 
  397
2018
 
  397
2019
 
  397
2020
 
  397
2021-2023
  427
 
 
$2,485
 
 
 
9

 
 
9. 
Related party transactions
 
 
Effective June 1, 2010, the Company relocated its headquarters to the offices of Bedford Oak in Mount Kisco, New York. Bedford Oak is controlled by Harvey P. Eisen, Chairman, Chief Executive Officer and a director of the Company. The Company has been subleasing a portion of the Bedford Oak space and has access to various administrative support services on a month-to-month basis.  On October 31, 2012, the Company’s Audit Committee approved an increase to approximately $40,700 per month (effective as of September 1, 2012) in the monthly sublease and administrative support services rate, which increased rate the Company believed, was necessary to provide for the increased personnel and space requirements necessary for an operating company.   

On May 13, 2014, the Company’s Audit Committee approved a decrease to approximately $27,600 per month (effective as of June 1, 2014) in the monthly sublease and administrative support services rate, which decreased rate is part of the Company’s effort to control and reduce costs.  Operating expenses for the quarters ended March 31, 2015 includes $83,000 related to the sublease arrangement with Bedford Oak. See Note 12 (a) for a description and the terms of the Company’s sublease transaction for its new corporate headquarters.  In March 2015, the Audit Committee approved the elimination of the monthly sublease and administrative support services fee effective March 31, 2015 as a result of the Company’s relocation to its new corporate headquarters.

 
Wright acts as an investment advisor, its subsidiary acts as a principal underwriter and one officer of Winthrop is also an officer for a family of mutual funds from which investment management and distribution fees are earned based on the net asset values of the respective funds.   Such fees, which are included in Other investment advisory services, amounted to $206,000 and $209,000 for the quarters ended March 31, 2016 and 2015, respectively.
 


10. 
Income taxes
 

For the three months ended March 31, 2016 and 2015,  income tax expense  of $16,000 and $17,000, respectively,  represents minimum state taxes. No tax benefit has been recorded in relation to the pre-tax loss for the three months ended March 31, 2016 and 2015, due to the Company providing a full valuation allowance to offset any deferred tax asset related to net operating loss carry forwards attributable to the losses.
 
 

11. 
Retirement plans
 

 
a)
The Company maintains a 401(k) Savings Plan (the “Plan”), for full time employees who have completed at least one hour of service coincident with the first day of each month.  The Plan permits pre-tax contributions by participants.   Effective January 15, 2013, the employees of Winthrop and its subsidiaries were eligible to participate in the Plan, and the Company ceased matching the participants contributions.

 
b)
Winthrop maintains an officer retirement bonus plan (the “Bonus Plan”) that is an unfunded deferred compensation program providing retirement benefits equal to 10% of annual compensation, as defined, to those officers upon their retirement.   Effective December 1, 1999, the Plan was frozen so that no additional benefits will be earned.  The present value of the obligation under the Bonus Plan at March 31, 2016, is $884,000, of which $200,000 is estimated to be payable over the next twelve months.  The liability is payable to individual retired employees at the rate of $50,000 per year in equal monthly amounts commencing upon retirement.  The liability was recorded at $885,000 at the date of acquisition, representing its estimated fair value computed based on its present value, utilizing a discount rate of 14%, which was estimated to be the acquired company’s weighted average cost of capital on such date from the perspective of a market participant.  The calculated discount of $1,027,000 at the date of acquisition is being amortized as interest expense over the period the obligation is outstanding by use of the effective interest method.  For the three months ended March 31, 2016 and 2015, interest expense, included in Interest expense and other income (loss), net amounted to $20,000 and $37,000, respectively. At March 31, 2016, the present value of the obligation under the Bonus Plan was $884,000, net of discount of $586,000.
 
 
10

 
 
12. 
Contingencies and commitments
 


(a)
On July 1, 2014, Winthrop, pursuant to the terms of its Milford facility lease, gave eight months’ notice to their landlord to terminate their lease in Milford, Connecticut.  In August 2014, the Company entered into a five year sublease in Greenwich, Connecticut for 10,000 square feet.  At March 31, 2016, annual future rent for the Greenwich, Connecticut space, under the sublease which expires on September 30, 2019 aggregated $879,000 payable as follows; $180,000 (remaining in 2016), $248,000 (2017), $255,000 (2018), and $196,000 (through September 30, 2019).   The Company moved their corporate office from Mount Kisco, New York to the new Greenwich, Connecticut facility in March 2015, which resulted in a consolidation of the Company’s operations.
 
(b)
On September 26, 2014, the Connecticut Department of Energy and Environmental Protection (“DEEP”) issued two Orders requiring the investigation and repair of two dams in which the Company and its subsidiaries have certain ownership interests.  The first Order requires that the Company investigate and make specified repairs to the ACME Pond Dam located in Killingly, Connecticut.  The second Order, as subsequently revised by DEEP on October 10, 2014, requires that the Company investigate and make specified repairs to the Killingly Pond Dam located in Killingly, Connecticut.  The Company has administratively appealed and contested the allegations in both Orders.  As the administrative appeal of both Orders is in its early stages, it is not possible at this time to evaluate the likelihood of, or to estimate the range of loss from, an unfavorable outcome.
 
 
11

 
 
13.
Segment information


The Company through its wholly-owned subsidiaries has one operating segment which is engaged in the investment management and financial advisory business and which derives its revenue from investment management services, other investment advisory services and financial research.
 
The Company’s corporate operations are not considered an operating segment and the Company does not allocate corporate expense for management and administrative services or income and expense related to other corporate activity to its operating segment to measure its operations.  The Company’s management utilizes adjusted EBITDA to measure segment performance.  Adjusted EBITDA is a measure defined as EBITDA before corporate expense, equity based compensation, amortization of stay and retention bonuses, relocation and severance costs and non-operating income (expense).   EBITDA is a measure defined as earnings (loss) before interest, taxes, depreciation and amortization
 
Adjusted EBITDA is a non-GAAP measure and should not be construed as an alternative to operating loss or net loss as an indicator of the Company’s performance, or as an alternative to cash used in operating activities, or as a measure of liquidity, or as any other measure determined in accordance with GAAP.

 
Following is a reconciliation of adjusted EBITDA of the operating segment to loss before income taxes (in thousands):
 

   
Three months ended March 31,
 
   
2016
   
2015
 
Adjusted EBITDA of operating segment
  $ 168     $ 18  
                 
Other operating expenses:
               
Corporate
    (398 )     (588 )
Depreciation and amortization
    (163 )     (164 )
Equity based compensation
    (54 )     (72 )
Amortization of stay and retention bonuses
    -       (37 )
Relocation and severance costs
    (72 )     (56 )
                 
Operating loss
    (519 )     (899 )
                 
Non- operating income (expense):
               
Interest expense and other (loss) income, net
    28       (37 )
Change in fair value of contingent consideration
    -       112  
                 
Loss from before income taxes
  $ (491 )   $ (824 )
                 
                 
Following is a summary of the Company's total
assets (in thousands):
               
   
March 31,
   
December 31,
 
    2016     2015  
Operating segment
  $ 6,747     $ 7,125  
Corporate (1)
    8,911       9,158  
    $ 15,658     $ 16,283  
 
(1) Consists principally of cash and cash equivalents
 
 
12

 
 
 
Cautionary Statement Regarding Forward-Looking Statements
 
This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward looking statements. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. The words “may,” “will,” “anticipate,” “should,” “would,” “believe,” “contemplate,” “could,” “project,” “predict,” “expect,” “estimate,” “continue,” and “intend,” as well as other similar words and expressions of the future, are intended to identify forward-looking statements.
 
Factors that may cause actual results to differ from those results expressed or implied, include, but are not limited to, those listed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 filed by the Company with the Securities and Exchange Commission (the “SEC”) on March 24, 2016.
 
These forward-looking statements generally relate to our plans, objectives and expectations for future events and include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts.  These statements are based upon our opinions and estimates as of the date they are made.  Although we believe that the expectations reflected in these forward-looking statements are reasonable, such forward-looking statements are subject to known and unknown risks and uncertainties that may be beyond our control, which could cause actual results, performance and achievements to differ materially from results, performance and achievements projected, expected, expressed or implied by the forward-looking statements.  While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the differences could be significant. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report and you are urged to consider all such risks and uncertainties. In light of the uncertainty inherent in such forward-looking statements, you should not consider their inclusion to be a representation that such forward-looking matters will be achieved.
 
 

Results of Operations

Assets Under Management (AUM)
 
Winthrop earns revenue primarily by charging fees based upon AUM.  At March 31, 2016, AUM was $1.39 billion, as compared to $1.44 billion at December 31, 2015.  The change in AUM was due to deposits of $63 million and increased market value of $18 million, offset by redemptions and withdrawals of $132 million.

 
Three months ended March 31, 2016 compared to the three months ended March 31, 2015
 
For the three months ended March 31, 2016, the Company had a loss from operations before income taxes of $491,000 compared to a loss from operations before income taxes of $824,000 for the three months ended March 31, 2015.   The decreased loss of $333,000 was primarily the result of reduced Other operating expenses of $178,000 and reduced Compensation and benefits of $203,000, partially offset by $112,000 of income related to the Change in fair value of contingent consideration recognized during the three months ended March 31, 2015. (see Note 2 to the Condensed Consolidated Financial Statements).    Included in the loss incurred for the three months ended March 31, 2016 and 2015, respectively,  for Winthrop are amortization of intangibles of $159,000 and $160,000 , amortization of stay and retention bonuses of $0 and $34,000 and compensation expense of $1,000 and $61,000 related to RSU’s issued to Winthrop employees.
 
The Company’s management utilizes Adjusted EBITDA to measure performance of its operating segment.  See Note 13 to the Condensed Consolidated Financial Statements for Adjusted EBITDA of the operating segment and a reconciliation of Loss before income taxes.
 
 
13

 
 
Revenue
 
Winthrop markets its investment management products and services to plan sponsors, trade unions, endowments, corporations, state and local governments, municipalities and foundations.  The Winthrop products include equity, fixed income and balanced portfolios for various plan types, including defined benefit, annuity, self-directed and 401(k), health and welfare and education and training plans. In addition, Wright helps bank trust departments and trust companies satisfy part or all of their investment management functions.  Winthrop delivers fiduciary level investment management services to these institutions’ clients by providing active oversight of each account's asset allocation and security selection.  Its offerings include investment management solutions utilizing individual securities or mutual funds. Mutual fund models developed by Winthrop utilize a combination of Wright Mutual Funds as well as mutual funds from other investment managers.
 
WPAM offers programs to support high net worth investors and other individual investors.  WPAM manages a variety of accounts including: discretionary investment accounts, individual retirement accounts (IRAs), 401k plans and accounts for non-corporate fiduciaries, such as trustees, executors, guardians, personal representatives, attorneys and other professionals who are responsible for the assets of others and must manage those assets in accordance with the Prudent Investor Act.  This investment process, developed and monitored by the Wright Investment Committee, and related investment strategies, are utilized to address the objectives of WPAM clients.
 
Winthrop, through its WISDI affiliate, offers a diversified family of mutual funds. Wright Mutual Funds are utilized by the Wright Companies and others to build or supplement managed investment portfolios designed to address clients’ financial objectives.
 
Revenue from Investment Management Services was $588,000 and $623,000 for the three months ended March 31, 2016 and 2015, respectively. Within this category, Winthrop primarily bills clients based on AUM values as of calendar quarters.  Revenues are primarily from fees from; (i) Taft-Hartley clients, (ii) Personal Investment Managed Accounts, (iii) and other client serviced accounts.  The reduced revenue of $35,000 was attributable to decreased AUM of $14,000,000 within the Personal Managed Accounts, which maintains a higher fee structure than the Taft-Hartley business, which business had increased AUM for the comparable periods of $10,000,000.
 
Revenue from Other investment advisory services was $714,000 and $697,000 for the three months ended March 31, 2016 and 2015, respectively.   The increased revenues of $17,000 were primarily due to increased revenue from Mutual Funds.  Other investment advisory service revenue includes: (i) revenue from Mutual Funds; (ii) fees from services provided to Bank Trust Departments; and (iii) investment income.  Revenue from Mutual Funds includes distribution fees for both Winthrop-sponsored mutual funds as well as other mutual funds and investment management fees from Winthrop-sponsored mutual funds.
 
Revenue from the sale of Financial research information and related data was $175,000 and $158,000 for the three months ended March 31, 2016 and 2015, respectively.  Revenues are also derived from the distribution of investment research directly and through several third parties who act as distributors of such research content.  The fees paid by the end client are divided between Winthrop and the distributor.  Existing agreements in place with third party distributors, primarily Thomson Reuters, allow for the renegotiation of the revenue split, which could result in a decline in revenue to Winthrop.   In addition, the underlying data we utilize to produce our financial research and related data is primarily obtained from a third-party, Worldscope (currently owned by Thomson Reuters).  The Company concluded negotiations with Thomson Reuters in July 2014 and pays for the updates at the most favored vendor rate.  The agreement expires in 2024. 
 


Compensation and benefits

For the three months ended March 31, 2016, Compensation and benefits were $1,092,000 as compared to $1,295,000 for the three months ended March 31, 2015. 

The reduced Compensation and benefits of $203,000 were the result of reduced costs of $199,000 at Winthrop, as well as reduced expenses of $4,000 at the corporate level.  Included in Winthrop’s Compensation and  benefits for the three months ended March 31, 2016 and 2015 are the following; (i) stay and retention bonuses of $0 and $34,000 and (ii) compensation expense of $1,000 and $61,000 for the years ended March 31, 2016 and 2015, respectively, related to RSU’s issued to  Winthrop employees.   In addition, Winthrop recognized $72,000 of severance costs in the quarter ended March 31, 2016.


Other operating expenses
 
For the three months ended March 31, 2016, Other operating expenses were $904,000 as compared to $1,082,000 for the three months ended March 31, 2015.  
 
 
14

 
 
The reduced operating expenses of $178,000 were the result of reduced operating expenses at the corporate level of $186,000 primarily due to reduced facility costs related to the move to the Company’s new Greenwich, Connecticut headquarters, as well as reduced professional fees and maintenance costs. Included in Winthrop’s Other operating expenses for the years ended March 31, 2016 and 2015 is amortization of intangibles of $159,000 and $160,000, respectively.
 
 
 
Income taxes
 
 For the three months ended March 31, 2016 and 2015, the Company recorded income tax expense of $16,000 and $17,000, respectively, which represents minimum state taxes. No tax benefit has been recorded in relation to the pre-tax loss for the three months ended March 31, 2016 and 2015, due to a full valuation allowance to offset any deferred tax asset related to net operating loss carry forwards attributable to the loss.


 Other Assets
 
The Company owns certain non-strategic assets, including interests in land and flowage rights in undeveloped property in Killingly, Connecticut.  

The Company monitors these investments for impairment by considering current factors, including the economic environment, market conditions, operational performance and other specific factors relating to the business underlying the investment, and records impairments in carrying values when necessary.   


Financial condition
 
Liquidity and Capital Resources

At March 31, 2016, the Company had cash and cash equivalents totaling $8,227,000, which it intends to use to acquire interests in one or more operating businesses and to fund the Company’s operating activities.
 
The decrease in cash and cash equivalents of $266,000 for the quarter ended March 31, 2016 was primarily the result of $410,000 used in operations, partially offset by $144,000 provided by investing activities.
 
 
15

 
 
 
Not required.
 
 
The Company’s principal executive officer and principal financial officer, with the assistance of other members of the Company’s management, have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based upon such evaluation, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report.
 
The Company’s principal executive officer and principal financial officer have also concluded that there was no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2016 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
 
16

 
 
PART II. OTHER INFORMATION
 
 
Issuances of Equity Securities
 
None

 
Purchases of Equity Securities
 
On December 15, 2006, the Board of Directors authorized the Company to repurchase up to 2,000,000 shares, or approximately 11%, of its outstanding shares of common stock from time to time either in open market or privately negotiated transactions. On August 13, 2008, the Company’s Board of Directors authorized an increase of 2,000,000 common shares to be repurchased, and on March 29, 2011 the Company’s Board of Directors authorized an increase of an additional 1,000,000 shares to be repurchased. At March 31, 2016, the Company had repurchased 1,791,971 shares of its common stock and, a total of 3,208,029 shares remained available for repurchase.   There were no common stock repurchases made by or on behalf of the Company during the quarter ended March 31, 2016.
 
 
17

 
 
 
Exhibit No.     
 
 Description
     
     
31.1
*     
Certification of principal executive officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
     
31.2
*
Certification of principal financial officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
     
32.1
*
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the principal executive officer of the Company and the principal financial officer of the Company
     
101.INS
**
XBRL Instance Document
     
101.SCH
**
XBRL Taxonomy Extension Schema Document
     
101.CAL
**
XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF
**
XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB
**
XBRL Extension Labels Linkbase Document
     
101.PRE
**   
XBRL Taxonomy Extension Presentation Linkbase Document
 
                                                           
 
*Filed herewith

**Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Act of 1934 and otherwise are not subject to liability.
 
 
18

 
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed in its behalf by the undersigned thereunto duly authorized.
 
 
 
   
WRIGHT INVESTORS’ SERVICE HOLDINGS, INC.
     
     
Date: May 11, 2016
 
/s/ HARVEY P. EISEN
   
Name: Harvey P. Eisen
   
Title: Chairman of the Board and Chief Executive Officer
     
     
     
Date: May 11, 2016
 
/s/ IRA J. SOBOTKO
   
Name: Ira J. Sobotko
   
Title: Vice President, Chief Financial Officer
 
 
19

EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
Exhibit 31.1

CERTIFICATIONS

I, Harvey P. Eisen, certify that:

 
1.
I have reviewed this quarterly report on Form 10-Q of Wright Investors’ Service Holdings, Inc.

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 11, 2016

/s/ HARVEY P. EISEN
 
Name:
Harvey P. Eisen
 
Title:
Chief Executive Officer
(Principal Executive Officer)
 
 
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm
Exhibit 31.2

CERTIFICATIONS

I, Ira J. Sobotko, certify that:

 
1.
I have reviewed this quarterly report on Form 10-Q of Wright Investors’ Service Holdings, Inc.

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 11, 2016

/s/ IRA J. SOBOTKO
 
Name:
Ira J. Sobotko
 
Title:
Vice President, Chief Financial Officer
(Principal Financial Officer)
 
 
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report on Form 10-Q of Wright Investors’ Service Holdings, Inc. (the “Company”) for the fiscal quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof, (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 
/s/ HARVEY P. EISEN
 
Name:
Harvey P. Eisen
 
Title:
Chief Executive Officer
(Principal Executive Officer)
 
Date:
May 11, 2016
 

/s/ IRA J. SOBOTKO
 
Name:
Ira J. Sobotko
 
Title:
Vice President, Chief Financial Officer
(Principal Financial Officer)
 
Date:
May 11, 2016
 
 
 
 

EX-101.INS 5 wish-20160331.xml EXHIBIT 101.INS 0001279715 2016-01-01 2016-03-31 0001279715 2015-01-01 2015-03-31 0001279715 2016-03-31 0001279715 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001279715 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-03-31 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001279715 2016-05-11 0001279715 wish:OperatingSegmentMember 2016-03-31 0001279715 us-gaap:CorporateMember 2016-03-31 0001279715 wish:OperatingSegmentMember 2016-01-01 2016-03-31 0001279715 wish:OperatingSegmentMember 2015-01-01 2015-03-31 0001279715 wish:OperatingSegmentMember 2015-12-31 0001279715 us-gaap:CorporateMember 2015-12-31 0001279715 2015-12-31 0001279715 2014-12-31 0001279715 2015-03-31 0001279715 us-gaap:CommonStockMember 2015-12-31 0001279715 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001279715 us-gaap:RetainedEarningsMember 2015-12-31 0001279715 us-gaap:TreasuryStockMember 2015-12-31 0001279715 us-gaap:CommonStockMember 2016-01-01 2016-03-31 0001279715 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0001279715 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0001279715 us-gaap:TreasuryStockMember 2016-01-01 2016-03-31 0001279715 us-gaap:CommonStockMember 2016-03-31 0001279715 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001279715 us-gaap:RetainedEarningsMember 2016-03-31 0001279715 us-gaap:TreasuryStockMember 2016-03-31 0001279715 wish:BusinessAcquisitionAcquireeOneMember 2012-12-01 2012-12-19 0001279715 wish:BusinessAcquisitionAcquireeOneMember 2012-12-19 0001279715 wish:BusinessAcquisitionAcquireeOneMember 2015-01-01 2015-12-31 0001279715 wish:BusinessAcquisitionAcquireeOneMember 2015-01-01 2015-03-31 0001279715 us-gaap:CustomerContractsMember 2016-01-01 2016-03-31 0001279715 us-gaap:CustomerContractsMember 2016-03-31 0001279715 us-gaap:TrademarksMember 2016-01-01 2016-03-31 0001279715 us-gaap:TrademarksMember 2016-03-31 0001279715 us-gaap:OtherIntangibleAssetsMember 2016-01-01 2016-03-31 0001279715 us-gaap:OtherIntangibleAssetsMember 2016-03-31 0001279715 2015-01-01 2015-12-31 0001279715 wish:BedfordOakMember us-gaap:LeaseAgreementsMember 2012-10-31 0001279715 wish:BedfordOakMember us-gaap:LeaseAgreementsMember 2014-05-13 0001279715 wish:BedfordOakMember us-gaap:LeaseAgreementsMember 2015-01-01 2015-03-31 0001279715 us-gaap:SubsidiariesMember 2016-01-01 2016-03-31 0001279715 us-gaap:SubsidiariesMember 2015-01-01 2015-03-31 0001279715 us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-03-31 0001279715 us-gaap:PensionPlansDefinedBenefitMember 2016-03-31 0001279715 us-gaap:PensionPlansDefinedBenefitMember 2015-01-01 2015-03-31 0001279715 wish:EgsLlcMember 2015-04-01 2015-04-28 0001279715 wish:EgsLlcMember 2015-04-28 0001279715 wish:MarshallGellerMember wish:EgsLlcMember 2015-04-01 2015-04-28 0001279715 wish:MarshallGellerMember wish:EgsLlcMember 2015-04-28 0001279715 wish:MerrimanHoldingsIncMember 2015-04-01 2015-04-28 0001279715 wish:MerrimanHoldingsIncMember 2015-04-28 0001279715 2015-04-28 0001279715 2015-04-01 2015-04-28 0001279715 wish:EgsLlcMember 2016-03-31 0001279715 wish:EgsLlcMember 2016-01-01 2016-03-31 0001279715 wish:EgsLlcMember 2015-12-31 0001279715 wish:MerrimanHoldingsIncMember 2016-03-31 0001279715 wish:MerrimanHoldingsIncMember 2015-12-31 0001279715 wish:MerrimanHoldingsIncMember 2016-01-01 2016-03-31 0001279715 wish:MerrimanCapitalIncMember 2016-03-31 0001279715 wish:MerrimanHoldingsIncMember wish:MarshallGellerMember 2015-04-28 0001279715 wish:MerrimanHoldingsIncMember wish:MarshallGellerMember 2015-04-01 2015-04-28 0001279715 wish:PlanNameOneMember 2016-03-31 0001279715 wish:PlanNameTwoMember 2016-03-31 0001279715 2016-03-01 2016-03-28 0001279715 2016-03-01 2016-03-31 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2012-12-01 2012-12-19 0001279715 us-gaap:RestrictedStockUnitsRSUMember wish:FourKeyExecutivesGroupOneMember 2012-12-01 2012-12-19 0001279715 us-gaap:RestrictedStockUnitsRSUMember wish:FourKeyExecutivesGroupOneMember 2012-12-19 0001279715 us-gaap:RestrictedStockUnitsRSUMember wish:FourKeyExecutivesGroupTwoMember 2012-12-01 2012-12-19 0001279715 us-gaap:RestrictedStockUnitsRSUMember wish:FourKeyExecutivesGroupTwoMember 2012-12-19 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-12-31 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001279715 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001279715 wish:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2014-02-01 2014-02-01 0001279715 wish:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001279715 wish:EmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001279715 wish:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2014-06-01 2014-06-10 0001279715 wish:EmployeeMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001279715 wish:TwoNewlyAppointedDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001279715 wish:TwoNewlyAppointedDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-01-19 0001279715 wish:TwoNewlyAppointedDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001279715 wish:TwoNewlyAppointedDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2016-03-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 5000000 1791971 3208029 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table align="center" border="0" cellpadding="0" cellspacing="0" width="100%" style="font-family: times new roman; font-size: 10pt;"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">4.&#160;</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Capital Stock&#160;</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company's Board of Directors, without any vote or action by the holders of common stock, is authorized to issue preferred stock from time to time in one or more series and to determine the number of shares and to fix the powers, designations, preferences and relative, participating, optional or other special rights of any series of preferred stock.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Board of Directors authorized the Company to repurchase up to <font>5,000,000</font> outstanding shares of common stock from time to time either in open market or privately negotiated transactions. At March 31, 2016, the Company had repurchased <font>1,791,971</font> shares of its common stock and a total of <font>3,208,029</font> shares, remained available for repurchase at March 31, 2016.</font></div> </div> 11000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt;"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">1.</font></div> </td> <td> <div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Basis of presentation and description of activities</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline;">Basis of presentation</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">The accompanying interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.&#160;&#160;The information and note disclosures normally included in complete financial statements have been condensed or omitted pursuant to such rules and regulations. &#160;The Condensed Consolidated Balance Sheet as of December 31, 2015 has been derived from audited financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2015 as presented in our Annual Report on Form 10-K. In the opinion of management, this interim information includes all material adjustments, which are of a normal and recurring nature, necessary for a fair presentation. The results for the 2016 interim period are not necessarily indicative of results to be expected for the entire year.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline;">Description of activities</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">On December 19, 2012 (the &#147;Closing Date&#148;), National Patent Development Corporation, which changed its name on February 4, 2013 to Wright Investors' Service Holdings, Inc. (hereinafter referred to as the &#147;Company&#148; or &#147;Wright Holdings&#148;), completed the acquisition of The Winthrop Corporation, a Connecticut corporation (&#147;Winthrop&#148;)&#160;pursuant to that certain&#160;&#160;Agreement and Plan of Merger (the &#147;Merger Agreement&#148;) dated June 18, 2012. Winthrop, through its wholly-owned subsidiaries Wright Investors' Service, Inc. (&#147;Wright&#148;), Wright Investors' Service Distributors, Inc. (&#147;WISDI&#148;) and Wright's wholly-owned subsidiary, Wright Private Asset Management, LLC (&#147;WPAM&#148;) (collectively, the &#147;Wright Companies&#148;), offers investment management services,&#160;&#160;financial advisory services and investment research to large and small investors, both taxable and tax exempt.&#160;&#160;WISDI is a registered broker dealer with the Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;) and the Securities and Exchange Commission.&#160;&#160;In accordance with the Merger Agreement, a wholly-owned newly formed subsidiary of the Company, was merged with and into Winthrop and Winthrop became a wholly-owned subsidiary of the Company.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">Critical accounting policies and estimates</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify">&#160;</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">There have been no changes to our critical accounting policies and estimates in the three months ended March 31, 2016. The Securities and Exchange Commission (&#147;SEC&#148;) defines &#147;critical accounting policies&#148; as those that require application of management's most difficult subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Our significant accounting policies are described under &#147;Critical Accounting Policies&#148; in our &#147;Management's Discussion and Analysis of Financial Condition and Results of Operations&#148; included in Item 7, as well as in our consolidated financial statements and footnotes thereto for the year ended December 31, 2015, as filed with the Commission with our Annual Report form 10-K filed on March 23, 2016.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">Reclassification</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">The Company has reclassified $<font>11,000</font> of Compensation and benefits for the period ended March 31, 2015 to Other operating expenses in order to be consistent with the presentation for the period ended March 31, 2016.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"></div></div> 852228 1900000 236000 -336000 -112000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt;"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">2.</font></div> </td> <td> <div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Contingent Consideration</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">In connection with the Company's acquisition of Winthrop on December 19, 2012, the Company had agreed to pay contingent consideration in cash to a holder of Winthrop common stock who received <font>852,228</font> shares of Company Common Stock to the extent that such shares have a value of less than $<font>1,900,000</font> on the expiration of the <font>three</font> year period based on the average closing price of the Company's Common Stock for the <font>ten</font> trading days prior to such date.&#160;&#160;A liability was recognized for an estimate of the acquisition date fair value of the acquisition-related contingent consideration which may be paid.&#160;&#160; Changes in the fair value of the contingent consideration subsequent to the acquisition date were recognized in earnings until the liability was eliminated or settled. In December 2015, the Company paid $<font>236,000</font> to settle the contingent consideration liability and recognized income of $<font>336,000</font> for the reduction in the fair value of the liability during the year ended December 31, 2015. The Company recognized income of $<font>112,000</font> for the change in the fair value of the liability for the three months ended March 31, 2015.</font></div></div> 19198000 19229000 35706 608526 3375000 133332 332923 788000 172000 4574000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">3.&#160;</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Per share data</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Loss per share for the three months ended March 31, 2016 and 2015, respectively, is calculated based on <font>19,198,000</font> and <font>19,229,000</font> weighted average outstanding shares of common stock.&#160;&#160;Included in these shares are vested RSUs of <font>35,706</font> and <font>608,526</font> for the quarters ended March 31, 2016 and 2015, respectively.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Options for <font>3,375,000</font> shares of common stock for the three months ended March 31, 2016 and 2015, and unvested RSUs for <font>133,332</font> and <font>332,923</font> shares of common stock, respectively, for the three months&#160;&#160;ended March 31, 2016 and 2015 were not included in the diluted computation as their effect would be anti-dilutive since the Company incurred net losses&#160;for both periods.</font></div> </div> 3000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">5.</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Short-term investments</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Short-term investments, which at December 31, 2015 consisted of mutual funds managed by a subsidiary of Winthrop are stated at the net asset value of the funds and are accounted for as trading securities with unrealized gain or loss included in Interest expense and other income (loss), net in the Condensed Consolidated Statements of Operations.&#160;&#160;The Company liquidated these investments in the first quarter of 2016 for proceeds of $<font>148,000</font> and realized a loss of $<font>9,000</font>.&#160;&#160;&#160;Unrealized &#160;gains on short term investments amounted to $<font>3,000</font> during the three months ended March 31, 2015.</font></div> </div> P9Y 3181000 1159000 2022000 P10Y 433000 142000 291000 P4Y 960000 2089000 2485000 159000 160000 P4Y9M 470000 397000 397000 397000 397000 427000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"><tr valign="top"><td style="WIDTH: 27pt;"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">8.&#160;</font></div> </td> <td> <div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Intangible Assets</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 19.8pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">At March 31, 2016, intangible assets subject to amortization which were recorded in connection with the acquisition of Winthrop consisted of the following (in thousands):</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div align="left"> <div><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" cellpadding="0" cellspacing="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px;" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">Intangible</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Estimated</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">useful life</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Gross</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">carrying</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">amount</font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Accumulated</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Amortization</font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Net</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">carrying</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">amount</font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Investment management and Advisory&#160;Contracts</font></div> </td> <td valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>9</font> years</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>3,181</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>1,159</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>2,022</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Trademarks</font></div> </td> <td valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;&#160; <font>10</font> years</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"> <font>433</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>142</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>291</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Proprietary software and</font></div> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">technology</font></div> </td> <td style="PADDING-BOTTOM: 2px;" valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;&#160;&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>4</font> years</font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>960</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>788</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>172</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>4,574</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>2,089</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>2,485</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr></table></div> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">For the three month periods ended March 31, 2016 and 2015, amortization expense was $<font>159,000</font> and $<font>160,000</font>, respectively. The weighted-average amortization period for total amortizable intangibles at March 31, 2016 is <font>4.75</font> years.&#160;&#160;Estimated amortization expense for each of the five succeeding years and thereafter is as follows (in thousands):</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div align="left"> <div><div style="display: block;"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" cellpadding="0" cellspacing="0" width="50%"> <tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-TOP: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Year ending December 31,</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-TOP: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;;font-family:'Times New Roman'" align="left" valign="top" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2016 (remainder)</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$<font>470</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2017</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2018</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2019</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2020</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2021-2023</font></div> </td> <td style="BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">&#160; <font>427</font></font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;;font-family:'Times New Roman'" align="left" valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="BORDER-BOTTOM: 1pt double; DISPLAY: inline; TEXT-DECORATION: underline;">$<font>2,485</font></font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> </tr></table></div></div> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;">&#160;</div></div> false --12-31 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" cellpadding="0" cellspacing="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px;" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">Intangible</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Estimated</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">useful life</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Gross</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">carrying</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">amount</font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Accumulated</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Amortization</font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;" colspan="2" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Net</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">carrying</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">amount</font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Investment management and Advisory&#160;Contracts</font></div> </td> <td valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>9</font> years</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>3,181</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>1,159</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>2,022</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Trademarks</font></div> </td> <td valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;&#160; <font>10</font> years</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"> <font>433</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>142</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>291</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" valign="bottom" width="42%"> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">Proprietary software and</font></div> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">technology</font></div> </td> <td style="PADDING-BOTTOM: 2px;" valign="bottom" width="22%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;&#160;&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>4</font> years</font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>960</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font>788</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>172</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="22%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>4,574</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>2,089</font></font></div> </td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: black 2px solid;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="left" valign="bottom" width="1%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">$</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid;" align="right" valign="bottom" width="9%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;"><font>2,485</font></font></div> </td> <td style="PADDING-BOTTOM: 2px;;font-family:'Times New Roman'" align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr></table></div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><div style="display: block;"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" cellpadding="0" cellspacing="0" width="50%"> <tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-TOP: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Year ending December 31,</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-TOP: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;;font-family:'Times New Roman'" align="left" valign="top" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2016 (remainder)</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">$<font>470</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2017</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2018</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2019</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2020</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; <font>397</font></font></div> </td> </tr><tr> <td style="BORDER-LEFT: #000000 0.5pt solid;" align="left" valign="top" width="60%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">2021-2023</font></div> </td> <td style="BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="DISPLAY: inline; TEXT-DECORATION: underline;">&#160; <font>427</font></font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> </tr><tr> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid;;font-family:'Times New Roman'" align="left" valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160; </font></td> <td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 0.5pt solid; BORDER-RIGHT: #000000 0.5pt solid;" align="left" valign="top" width="40%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;"><font style="BORDER-BOTTOM: 1pt double; DISPLAY: inline; TEXT-DECORATION: underline;">$<font>2,485</font></font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt;">&#160;</font></div> </td> </tr></table></div></div> 40700 27600 83000 206000 209000 Smaller Reporting Company 18919573 2016 Q1 588000 623000 714000 697000 175000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">9.&#160;</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Related party transactions</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;<br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Effective June 1, 2010, the Company relocated its headquarters to the offices of Bedford Oak in Mount Kisco, New York. Bedford Oak is controlled by Harvey P. Eisen, Chairman, Chief Executive Officer and a director of the Company. The Company has been subleasing a portion of the Bedford Oak space and has access to various administrative support services on a month-to-month basis.&#160;&#160;On October 31, 2012, the Company's Audit Committee approved an increase to approximately $<font>40,700</font> per month (effective as of September 1, 2012) in the monthly sublease and administrative support services rate, which increased rate&#160;the Company believed,&#160;was necessary to provide for the increased personnel and space requirements necessary for an operating company.&#160;&#160;&#160;</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On May 13, 2014, the Company's Audit Committee approved a decrease to approximately $<font>27,600</font> per month (effective as of June 1, 2014) in the monthly sublease and administrative support services rate, which decreased rate is part of the Company's effort to control and reduce costs.&#160;&#160;Operating&#160;expenses for the quarters ended March 31, 2015 includes $<font>83,000</font> related to the sublease arrangement with Bedford Oak. See Note 12 (a) for a description and the terms of the Company's sublease transaction for its new corporate headquarters.&#160;&#160;In March 2015, the Audit Committee approved the elimination of the monthly sublease and administrative support services fee effective March 31, 2015 as a result of the Company's relocation to its new corporate headquarters.</font></div> <div style="text-indent: 0pt; display: block;">&#160;<br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Wright acts as an investment advisor, its subsidiary acts as a principal underwriter and one officer of Winthrop is also an officer for a family of mutual funds from which investment management and distribution fees are earned based on the net asset values of the respective funds. &#160;Such fees, which are included in Other investment advisory services, amounted to $<font>206,000</font> and $<font>209,000</font> for the quarters ended March 31, 2016 and 2015, respectively.</font></div> </div> 16000 17000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">10.&#160;</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Income taxes</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">For the three months ended March 31, 2016 and 2015,&#160;&#160;income tax expense&#160;&#160;of $<font>16,000</font> and $<font>17,000</font>, respectively,&#160;&#160;represents minimum state taxes. No tax benefit has been recorded in relation to the pre-tax loss for the three months ended March 31, 2016 and 2015, due to the Company providing a full valuation allowance to offset any deferred tax asset related to net operating loss carry forwards attributable to the losses.</font></div></div> 3375000 Wright Investors Service Holdings, Inc. 0001279715 10-Q 2016-03-31 158000 1477000 1478000 1092000 1295000 904000 1082000 1996000 2377000 -519000 -899000 28000 -37000 112000 -491000 -824000 -16000 -17000 -507000 -841000 -0.03 -0.04 8227000 8493000 157000 359000 326000 8000 37000 373000 456000 8967000 9469000 44000 44000 2485000 2644000 3364000 3364000 321000 287000 355000 355000 122000 120000 15658000 16283000 874000 1030000 14000 200000 200000 1088000 1230000 684000 714000 1772000 1944000 197000 197000 33542000 33488000 -18494000 -17987000 565219 1359000 1359000 13886000 14339000 15658000 16283000 -9000 163000 164000 -112000 -2000 54000 72000 34000 33000 102000 3000 14000 1000 -30000 19000 -29000 -4000 -83000 -122000 -156000 72000 -410000 -604000 148000 4000 9000 144000 -9000 -266000 -613000 11163000 10550000 10000 19720971 197000 33488000 -17987000 -1359000 -507000 27000 27000 13821 27000 27000 19734792 197000 33542000 -18494000 -1359000 333333 333333 0.3333 333333 333333 0.3333 1000000 P1Y 1000000 0.12 P5Y 500000 1.00 166666 P5Y 0.25 34000 120000 321000 287000 14000 12000 2000 0.99998 166666 1.00 P5Y 1.29 1.34 0.50 0.52 0 0.4824 0.0121 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">6.</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Investment in LLC</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company entered into a Limited Liability Company Agreement dated April 28, 2015 by and among EGS, LLC,&#160;&#160;a newly formed Delaware limited liability company (&#147;EGS&#148;) and the members named therein.&#160;&#160;The Company invested $<font>333,333</font> and acquired <font>333,333</font> Units, representing a <font>33.33</font>% Membership Interest in EGS. In addition to the Company, EGS has two other members, one of whom is Marshall Geller, a member of the Company's Board of Directors. The EGS transaction, as well as Mr. Geller's participation in the transaction, received the prior approval of the Company's Audit Committee.&#160;&#160;Mr. Geller is the Managing Member of the LLC and also invested $<font>333,333</font> and acquired <font>333,333</font> Units, representing a <font>33.33</font>% Membership Interest in EGS.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">EGS entered into a Note Purchase Agreement effective April 28, 2015 with Merriman Holdings, Inc. (&#147;Merriman&#148;), a publically traded company,&#160;&#160;pursuant to which EGS purchased from Merriman for an aggregate purchase price of $<font>1,000,000</font>&#160;&#160;(i) a <font>one</font>-year&#160;&#160;Senior Secured Note in the original principal amount of $<font>1,000,000</font>, at <font>12</font>% interest, payable quarterly, in arrears (the &#147;Note&#148;) and (ii) a Common Stock Purchase Warrant which expires in <font>five</font> years to purchase <font>500,000</font> shares of Merriman common stock&#160;&#160;at $<font>1.00</font> per share (the &#147;Warrants&#148;).&#160;&#160;&#160;EGS distributed the Warrants to its members and the Company received <font>166,666</font> Warrants which expire in&#160;<font>five</font> years.&#160;&#160;On July 20, 2015, a fourth member joined EGS and invested $<font>333,333</font>, and received a <font>25</font>% Membership Interest in EGS.&#160;&#160;EGS advanced the funds to Merriman and increased its investment in the Note and in addition, received <font>166,666</font> additional Warrants which it distributed to its new member.&#160;&#160;This transaction reduced the Company's interest in EGS to <font>25</font>%, changed the expiration date of the Note to July 20, 2016, and extended the exercise date of the warrant to <font>five</font> years from that date. The investment in EGS is being accounted for under the equity method. Under this method, the Company records its share of EGS's earnings (losses) in the statement of operations with equivalent amount of increases (decreases) to the investment. The Company recorded approximately $<font>34,000</font> as its share of EGS's net income for the quarter ended March 31, 2016, which is included in Interest expense and other income (loss), net.&#160;&#160;At April 28, 2015, the Company valued the Warrants at their fair value, of $<font>120,000</font>, using the Black Scholes model, and recorded their value as a reduction in the investment in EGS.&#160;&#160;&#160;At March 31, 2016 and December 31, 2015, the carrying value of the investment in EGS was $<font>321,000</font> and $<font>287,000</font>, respectively. The Warrant which permits a cashless exercise,&#160;qualifies as a derivative, and is recorded at fair value (based on observable inputs) with change in such value included in earnings.&#160;&#160;&#160;At March 31, 2016 and December 31, 2015, the value of the Warrant (a Level 2 Security) was $<font>14,000</font> and $<font>12,000</font>, respectively, which is included in Other Assets in the Consolidated Balance Sheet.&#160;&#160;The increase in the value of the Warrant of $<font>2,000</font>&#160;&#160;for the quarter ended March 31, 2016 is included in Interest expense and other income (loss), net in the Consolidated Statement of Operations.&#160;&#160;Such increase reflects the increase in the price of Merriman's common stock as measured for the three months ended March 31, 2016.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Merriman is a financial services holding company that provides capital markets advisory and research, corporate and investment banking services through its wholly-owned principal operating subsidiary, Merriman Capital, Inc. (&#147;MC&#148;).&#160;&#160;The Note is secured by <font>99.998</font>% of the capital stock of MC.&#160;&#160;Marshall Geller also received <font>166,666</font> Warrants with an exercise price of $<font>1.00</font> per share that expire in <font>five</font> years.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Note, pursuant to the terms of an Intercreditor Agreement entered into with Merriman's current debt holders, is senior to all of Merriman's debt.</font></div></div> 3500000 7500000 P10Y P3Y 1.10 6116786 700000 100000 25000 3375000 3250000 2.27 P1Y8M12D 5000 59000 849280 479280 P3Y 2.52 0.20 2.02 966000 370000 P3Y 2.52 0.11 2.25 69000 252767 369000 596513 596513 17738 P3Y 2.40 0.11 2.25 1000 3000 30000 1.90 11000 100000 P3Y 1.70 1.85 0.08 1.56 1.70 26000 11000 205000 P2Y <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="font-family: times new roman; font-size: 10pt;" cellpadding="0" cellspacing="0" width="40%"> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Dividend yield</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>0</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>48.24</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>1.21</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (in years)</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>4</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table></div> 884000 586000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">7.</font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Incentive stock plans and stock based compensation</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="display: inline; text-decoration: underline;">Common stock options</font></font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company had initially adopted a stock-based compensation plan for employees and non-employee members of its Board of Directors in November 2003 (the &#147;2003 Plan&#148;), which was subsequently amended in March 2007 (the &#147;2003 Plan Amendment&#148;).&#160;&#160;In December 2007, the Company adopted the National Patent Development Corporation 2007 Incentive Stock Plan (the &#147;2007 NPDC Plan&#148;).&#160;&#160;The plans provide for up to <font>3,500,000</font> and <font>7,500,000</font> awards for shares under the 2003 Plan Amendment and 2007 NPDC Plan, respectively, in the form of discretionary grants of stock options, restricted stock shares, restricted stock units (RSUs) and other stock-based awards to employees, directors and outside service providers. The Company's plans are administered by the Compensation Committee of the Board of Directors, which consists solely of non-employee directors. The term of any option granted under the plans will not exceed <font>ten</font> years from the date of grant and, in the case of incentive stock options granted to a 10% or greater holder of total voting stock of the Company, <font>three</font> years from the date of grant.&#160;&#160;The exercise price of any option granted under the plans may not be less than the fair market value of the common stock on the date of grant or, in the case of incentive stock options granted to a 10% or greater holder of total voting stock, <font>110</font>% of such fair market value.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company recorded no compensation expense related to option grants for the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, the number of shares reserved and available for award under the 2007 NPDC Plan is <font>6,116,786</font> and under the 2003 Plan Amendment is <font>700,000</font>.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">During the three months ended March 31, 2016, the Company issued <font>100,000</font> options to a consultant on March 28, 2016 and <font>25,000</font> options to an employee on March 31, 2016.&#160;&#160;The options issued on March 28, 2016 vest equally over <font>3</font> years, and are subject to post vesting restrictions for sale for <font>three</font> years. The options issued on March 31, 2016 vest on the third anniversary of their issuance.&#160;&#160;The options were issued at an exercise price of $<font>1.29</font> and $<font>1.34</font> per share for the options issued on March 28, 2016 and March 31, 2016, respectively, equal to market value at the date of the grant.&#160;&#160;The grant-date fair value of the options were $<font>0.50</font> and $<font>0.52</font>, respectively, which was estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions:</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div align="left"> <div><table style="font-family: times new roman; font-size: 10pt;" cellpadding="0" cellspacing="0" width="40%"> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Dividend yield</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>0</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>48.24</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>1.21</font></font></div> </td> <td align="left" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">%</font></div> </td> </tr> <tr> <td align="left" valign="bottom" width="82%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (in years)</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="15%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="right"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>4</font></font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table></div> </div> <div style="text-indent: 0pt; display: block;"><br/> &#160;</div> <div style="text-indent: 0pt; display: block;"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The fair value of the options granted on March 28, 2016 were reduced by an <font>8</font>% discount.</font></div> </div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">During the three months ended March 31, 2015, there was no option activity.&#160;&#160;As of&#160;March 31, 2016, there were outstanding options to acquire <font>3,375,000</font> common shares, <font>3,250,000</font> of which were vested and exercisable, having a weighted average exercise price of $<font>2.27</font> per share,&#160;a weighted average&#160;contractual term of <font>1.7</font> years and an aggregate intrinsic value of $<font>5,000</font>.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">As of March 31, 2016, the unrecognized compensation expense related to non-vested options was $<font>59,000</font>.&#160;</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="font-style: italic; display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;"><font style="display: inline; text-decoration: underline;">Restricted stock units</font></font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">As a result of the Winthrop acquisition, the Company issued a total of <font>849,280</font> RSUs on the closing date to be settled in shares of Company common stock as follows:</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div> </td> <td style="width: 18pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">a)</font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font>479,280</font> RSUs were granted to four key executives of Winthrop, which vested as of the Closing Date and are subject to post-vesting restrictions on sale for <font>three</font> years.&#160;&#160;The RSUs were valued at the closing price of the Company's common stock of $<font>2.52</font>, less a <font>20</font>% discount for post vesting restrictions on sale, or $<font>2.02</font> per share.&#160;&#160;The total value of these RSUs of $<font>966,000</font>, were accounted for as compensation and charged to retention bonus expense on the closing date.</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;">&#160;</div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div> </td> <td style="width: 18pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">b)</font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font>370,000</font> RSUs were granted to four key executives, which vest&#160;&#160;equally over <font>three</font> years, with the first third vesting one year from the Closing Date.&#160;&#160;The RSUs were valued based on the closing price of the Company's common stock on the Closing Date of $<font>2.52</font>, less an average discount&#160;of <font>11</font>% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $<font>2.25</font>.&#160;The Company recorded compensation expense of $<font>69,000</font> for the quarter ended March 31, 2015 related to these RSUs.</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">At December 19, 2015, the above RSUs were fully vested.&#160;&#160;&#160;&#160;In December 2015, the Company repurchased <font>252,767</font> RSUs for a total cost of $<font>369,000</font>.&#160;&#160;The remaining <font>596,513</font> RSUs were settled by the issuance of <font>596,513</font> common shares in the first quarter of 2016. Such issuable shares are included in the outstanding common shares at December 31, 2015 in the accompanying financial statements.</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">In addition, the following RSUs were granted to employees of the Company:</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div> </td> <td style="width: 18pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">(c)</font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font>17,738</font> RSUs were granted to certain employees&#160;on February 4, 2013, which vest&#160;equally over <font>three</font> years, with the first third vesting on February 4, 2014.&#160;&#160;At March 31, 2016, <font>11,701</font> of the RSU's were fully vested.&#160;&#160;The RSUs are valued based on the closing price of the Company's common stock on February 4, 2013 of $<font>2.40</font>, less an average discount&#160;of <font>11</font>% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $<font>2.25</font>.&#160;&#160;The Company recorded compensation expense of $<font>1,000</font> and $<font>3,000</font>, respectively, for the quarters ended March 31, 2016 and 2015 related to these RSUs.&#160;&#160; There was no unrecognized compensation expense related to these unvested RSUs at March 31, 2016.</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;"><br/></div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160; </font></div> </td> <td style="width: 18pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">d)</font></div> </td> <td> <div align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font>30,000</font> RSUs were granted to an employee on June 10, 2014, which will vest on the third anniversary of the individual's employment, assuming the individual is still employed at that time.&#160;&#160;&#160;The RSUs are valued based on the closing price of the Company's common stock on June 10, 2014 of $<font>1.90</font>.&#160;&#160; For the quarter ended March 31, 2015,&#160;&#160;$<font>11,000</font> of compensation expense previously recorded during the year ended December 31, 2014 related to these RSUs was reversed since in the first quarter of 2015, the individual was no longer employed by the Company and the above RSUs were cancelled.&#160;</font></div> </td> </tr> </table> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <table style="font-family: times new roman; font-size: 10pt;" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt; ;font-family: 'Times New Roman';">&#160;</td> <td style="width: 18pt;" align="right"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">e)</font></div> </td> <td align="left"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On January 19, 2015 and March 31, 2015, <font>100,000</font> RSUs were issued on each date to two newly appointed directors of the Company.&#160; The RSUs will vest equally over <font>3</font> years.&#160; The RSUs are valued based on the closing price of the Company's common stock on January 19, 2015 and March 31, 2015 of $<font>1.70</font> and $<font>1.85</font>, respectively, less an average discount of <font>8</font>% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $<font>1.56</font> and $<font>1.70</font>, respectively.&#160; The Company recorded compensation expense of $<font>26,000</font> and $<font>11,000</font> for the quarters ended March 31, 2016 and 2015, respectively,&#160; related to these RSUs.&#160; The total unrecognized compensation expense related to these unvested RSUs at March 31, 2016 is $<font>205,000</font>, which will be recognized over the remaining vesting period of approximately <font>2</font> years.</font></div> </td> </tr> </table> </div> </div> 0.10 884000 200000 50000 885000 0.14 1027000 20000 37000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt;"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">11.&#160;</font></div> </td> <td> <div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Retirement plans</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt;"> <div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160; </font></div> </td> <td style="WIDTH: 18pt;"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">a)</font></div> </td> <td> <div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">The Company maintains a 401(k) Savings Plan (the &#147;Plan&#148;), for full time employees who have completed at least one hour of service coincident with the first day of each month.&#160;&#160;The Plan permits pre-tax contributions by participants.&#160;&#160;&#160;Effective January 15, 2013, the employees of Winthrop and its subsidiaries were eligible to participate in the Plan, and the Company ceased matching the participants contributions.</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt;"> <div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160; </font></div> </td> <td style="WIDTH: 18pt;"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">b)</font></div> </td> <td> <div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">Winthrop maintains an officer retirement bonus plan (the &#147;Bonus Plan&#148;) that is an unfunded deferred compensation program providing retirement benefits equal to <font>10</font>% of annual compensation, as defined, to those officers upon their retirement.&#160;&#160;&#160;Effective December 1, 1999, the Plan was frozen so that no additional benefits will be earned.&#160;&#160;The present value of the obligation under the Bonus Plan at March 31, 2016, is $<font>884,000</font>, of which $<font>200,000</font> is estimated to be payable over the next twelve months.&#160;&#160;The liability is payable to individual retired employees at the rate of $<font>50,000</font> per year in equal monthly amounts commencing upon retirement.&#160;&#160;The liability was recorded at $<font>885,000</font> at the date of acquisition, representing its estimated fair value computed based on its present value, utilizing a discount rate of <font>14</font>%, which was estimated to be the acquired company's weighted average cost of capital on such date from the perspective of a market participant.&#160;&#160;The&#160;calculated&#160;discount of $<font>1,027,000</font> at the date of acquisition&#160;is being amortized as interest expense over the period the obligation is outstanding by use of the effective interest method.&#160; For the three months ended March 31, 2016 and 2015, interest expense, included in Interest expense and other&#160;income (loss), net amounted to $<font>20,000</font> and $<font>37,000</font>, respectively. At March 31, 2016, the present value of the obligation under the Bonus Plan was $<font>884,000</font>, net of discount of $<font>586,000</font>.</font></div></td></tr></table></div> P5Y 879000 180000 248000 255000 196000 72000 56000 -519000 -899000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt;"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">12.&#160;</font></div> </td> <td> <div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;">Contingencies and commitments</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block;"><br/> </div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt;"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">(a)</font></div> </td> <td> <div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">On July 1, 2014, Winthrop, pursuant to the terms of its Milford facility lease, gave eight months' notice to their landlord to terminate their lease in Milford, Connecticut.&#160;&#160;In August 2014, the Company entered into a <font>five</font> year sublease in Greenwich, Connecticut for 10,000 square feet.&#160;&#160;At March 31, 2016, annual future rent for the Greenwich, Connecticut space, under the sublease which expires on September 30, 2019 aggregated $<font>879,000</font> payable as follows; $<font>180,000</font> (remaining in 2016), $<font>248,000</font> (2017), $<font>255,000</font> (2018), and $<font>196,000</font> (through September 30, 2019).&#160;&#160; The Company moved their corporate office from Mount Kisco, New York&#160;to the new Greenwich, Connecticut facility in March 2015, which resulted in a consolidation of the Company's operations.</font></div> </td> </tr></table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">&#160;</font></div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt;"> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt;"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">(b)</font></div> </td> <td> <div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;">On September 26, 2014, the Connecticut Department of Energy and Environmental Protection (&#147;DEEP&#148;) issued two Orders requiring the investigation and repair of two dams in which the Company and its subsidiaries have certain ownership interests.&#160; The first Order requires that the Company investigate and make specified repairs to the ACME Pond Dam located in Killingly, Connecticut.&#160; The second Order, as subsequently revised by DEEP on October 10, 2014, requires that the Company investigate and make specified repairs to the Killingly Pond Dam located in Killingly, Connecticut.&#160; The Company has administratively appealed and contested the allegations in both Orders.&#160; As the administrative appeal of both Orders is in its early stages, it is not possible at this time to evaluate the likelihood of, or to estimate the range of loss from, an unfavorable outcome.</font></div></td></tr></table></div> 168000 18000 -398000 -588000 163000 164000 54000 72000 -37000 28000 -37000 112000 -491000 -824000 6747000 7125000 8911000 9158000 <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <table style="font-family: times new roman; font-size: 10pt;" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 36pt;" align="right"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">13.</font></div> </td> <td align="left"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt; font-weight: bold;">Segment information</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company through its wholly-owned subsidiaries has <font>one</font> operating segment which is engaged in the investment management and financial advisory business and which derives its revenue from investment management services, other investment advisory services and financial research.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The Company's corporate operations are not considered an operating segment and the Company does not allocate corporate expense for management and administrative services or income and expense related to other corporate activity to its operating segment to measure its operations.&#160;&#160;The Company's management utilizes adjusted EBITDA to measure segment performance.&#160;&#160;Adjusted EBITDA is a measure defined as EBITDA before corporate expense, equity based compensation, amortization of stay and retention bonuses,&#160;relocation and severance costs and non-operating income (expense).&#160;&#160;&#160;EBITDA is a measure defined as earnings (loss) before interest, taxes, depreciation and amortization</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Adjusted EBITDA is a non-GAAP measure and should not be construed as an alternative to operating loss or net loss as an indicator of the Company's performance, or as an alternative to cash used in operating activities, or as a measure of liquidity, or as any other measure determined in accordance with GAAP.</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">Following is a reconciliation of adjusted EBITDA of the operating segment to loss before income taxes (in thousands):</font></div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; display: block;"><br/></div> <div align="left"> <div> <table style="font-family: times new roman; font-size: 10pt;" cellpadding="0" cellspacing="0" width="100%"> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td colspan="6" nowrap="nowrap" valign="bottom" width="22%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline; text-decoration: underline;">Three months ended March 31,</font></font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: black 2px solid;" colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2016</font></div> </td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2015</font></div> </td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Adjusted EBITDA of operating segment</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>168</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>18</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Other operating expenses:</font></font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Corporate</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(398</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(588</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Depreciation and amortization</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(163</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(164</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equity based compensation</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(54</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(72</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amortization of stay and retention bonuses</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>-</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(37</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Relocation and severance costs</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(72</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(56</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Operating loss</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(519</font> </font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(899</font> </font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Non- operating income (expense):</font></font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Interest expense and other (loss) income, net</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>28</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(37</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Change in fair value of contingent consideration</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>-</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>112</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 4px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Loss from before income taxes</font></div> </td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(491</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(824</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Following is a summary of the Company's total</font></div> <div style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">assets (in thousands):</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">March 31,</font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: -0.7pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31,</font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: center; ;font-family: 'Times New Roman';" colspan="2" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2016</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: center; ;font-family: 'Times New Roman';" colspan="2" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2015</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Operating segment</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>6,747</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>7,125</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Corporate (1)</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>8,911</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>9,158</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>15,658</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>16,283</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left">&#160;</div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">(1)&#160;</font></font>Consists principally of cash and cash equivalents</div> </div> <div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <table style="font-family: times new roman; font-size: 10pt;" cellpadding="0" cellspacing="0" width="100%"> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td colspan="6" nowrap="nowrap" valign="bottom" width="22%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline; text-decoration: underline;">Three months ended March 31,</font></font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: black 2px solid;" colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2016</font></div> </td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2015</font></div> </td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Adjusted EBITDA of operating segment</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>168</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>18</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Other operating expenses:</font></font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Corporate</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(398</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(588</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Depreciation and amortization</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(163</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(164</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equity based compensation</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(54</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(72</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amortization of stay and retention bonuses</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>-</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(37</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Relocation and severance costs</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(72</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(56</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Operating loss</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(519</font> </font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(899</font> </font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Non- operating income (expense):</font></font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Interest expense and other (loss) income, net</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>28</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(37</font> </font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Change in fair value of contingent consideration</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>-</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>112</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 4px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Loss from before income taxes</font></div> </td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>(491</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">)</font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>(824</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Following is a summary of the Company's total</font></div> <div style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">assets (in thousands):</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">March 31,</font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td colspan="2" nowrap="nowrap" valign="bottom" width="10%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: -0.7pt;" align="center"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 31,</font></div> </td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: center; ;font-family: 'Times New Roman';" colspan="2" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2016</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: center; ;font-family: 'Times New Roman';" colspan="2" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2015</font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Operating segment</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>6,747</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>7,125</font></font></td> <td style="text-align: left; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" align="left" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Corporate (1)</font></div> </td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>8,911</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 2px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>9,158</font></font></td> <td style="text-align: left; padding-bottom: 2px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font>15,658</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="padding-bottom: 4px; ;font-family: 'Times New Roman';" align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: #000000 4px double; text-align: left; ;font-family: 'Times New Roman';" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: #000000 4px double; text-align: right; ;font-family: 'Times New Roman';" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font>16,283</font></font></td> <td style="text-align: left; padding-bottom: 4px; ;font-family: 'Times New Roman';" nowrap="nowrap" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> 1 565219 P3Y 100000 0.08 Consists principally of cash and cash equivalents EX-101.SCH 6 wish-20160331.xsd EXHIBIT 101.SCH 001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 101 - Disclosure - Basis of presentation and description of activities link:presentationLink link:calculationLink link:definitionLink 103 - Disclosure - Per share data link:presentationLink link:calculationLink link:definitionLink 104 - Disclosure - Capital Stock link:presentationLink link:calculationLink link:definitionLink 110 - Disclosure - Income taxes link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Basis of presentation and description of activities (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Per share data (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Capital Stock (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Income taxes (Details) link:presentationLink link:calculationLink link:definitionLink 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 113 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 313 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 102 - Disclosure - Contingent Consideration link:presentationLink link:calculationLink link:definitionLink 106 - Disclosure - Investment in LLC link:presentationLink link:calculationLink link:definitionLink 108 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 308 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Contingent Consideration (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Investment in LLC (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Intangible Assets (Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Intangible Assets (Estimated Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 105 - Disclosure - Short-term investments link:presentationLink link:calculationLink link:definitionLink 109 - Disclosure - Related party transactions link:presentationLink link:calculationLink link:definitionLink 111 - Disclosure - Retirement plans link:presentationLink link:calculationLink link:definitionLink 112 - Disclosure - Contingencies and commitments link:presentationLink link:calculationLink link:definitionLink 107 - Disclosure - Incentive stock plans and stock based compensation link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Short-term investments (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Related party transactions (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Retirement plans (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Contingencies and commitments (Details) link:presentationLink link:calculationLink link:definitionLink 307 - Disclosure - Incentive stock plans and stock based compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Incentive stock plans and stock based compensation (Common Stock Options) (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Incentive stock plans and stock based compensation (Restricted Stock) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 wish-20160331_cal.xml EXHIBIT 101.CAL EX-101.DEF 8 wish-20160331_def.xml EXHIBIT 101.DEF EX-101.LAB 9 wish-20160331_lab.xml EXHIBIT 101.LAB Document And Entity Information [Abstract]. Document And Entity Information [Abstract] Change in the number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. Stock Repurchase Program Number Of Shares Authorized To Be Repurchased Increase Decrease Increase in the number of shares authorized to be repurchased Percentage of number of shares outstanding authorized for repurchase. Stock Repurchase Program Percent Of Outstanding Shares Authorized Percent of shares outstanding authorized to be repurchased Increase Decrease In Fair Value Of Contingent Consideration. IncreaseDecreaseInFairValueOfContingentConsideration Change in fair value of contingent consideration Change in fair value of contingent consideration Carrying amount as of the balance sheet date of Investment in undeveloped land InvestmentInUndevelopedLand Investment in undeveloped land Increase or decrease in settlement payable during the period. IncreaseDecreaseInSettlementPayable Settlement payable Cash Paid During Period [Abstract] CashPaidDuringPeriodAbstract Net cash paid during the period for Adjusted EBITDA is a measure defined as EBITDA before corporate expense, equity based compensation, amortization of stay and retention bonuses, relocation and severance costs and non-operating income (expense). EBITDA is a measure defined as earnings before interest, taxes, depreciation and amortization. AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization Adjusted EBITDA (income/(loss)) of operating segment Amendment Flag Operating Segment [Member] Business Acquisition Equity Interests Issued Contingent Consideration Maximum Value Of Shares. BusinessAcquisitionEquityInterestsIssuedContingentConsiderationMaximumValueOfShares Contingent consideration, maximum value of shares Number of equity units acquired from an investment following the equity method. EquityMethodInvestmentUnitsAcquired Units acquired The aggregate purchase price of a note purchase agreement. NotePurchaseAgreementAmount Note Purchase Agreement, aggregate purchase price The length of time that the warrants or rights are exercisable. ClassOfWarrantOrRightTerm Term of warrants Number of warrants owned by the noncontrolling interest. MinorityInterestWarrantsOwned Warrants owned by noncontrolling interests Percentage of capital stock that secures a note. DebtInstrumentPercentageOfCapitalStockSecuringNote Notes secured, percentage of capital stock Business Acquisition Acquiree One Member. Winthrop [Member] A holder of the acquired entity's stock who is not specifically identified. Nonspecified Stock Holder [Member] Merriman Holdings, Inc. [Member] Merriman Holdings, Inc. [Member] Senior Secured Note [Member]. Senior Secured Note [Member] Egs Llc [Member]. EGS [Member] Marshall Geller [Member]. Marshall Geller [Member] Merriman Capital, Inc. [Member]. Merriman Capital, Inc. [Member] Business Acquisition Common Stock Transfer Restriction Period. BusinessAcquisitionCommonStockTransferRestrictionPeriod Transfer restriction period Bedford Oak [Member] Bedford Oak [Member] Current Fiscal Year End Date Deferred Compensation Annual Liability Payable To Individual Retired Employees Deferred Compensation Annual Liability Payable To Individual Retired Employees Annual liability payable to individual retired employees Deferred Compensation Program Interest Expense Amount To Be Amortized. Deferred Compensation Program Interest Expense Amount To Be Amortized Amount to be amortized, as interest expense The amount of discount that was originally recognized that has yet to be amortized. Defined Benefit Plan Benefit Obligation Unamortized Discount Unamortized discount Employee [Member]. Employee [Member] Employees [Member] Employees [Member] Employment Agreements Annual Base Salary. Employment Agreements Annual Base Salary Annual base salary Equity Issuance Per Share Amount After Post Vesting Restrictions Discount. EquityIssuancePerShareAmountAfterPostVestingRestrictionsDiscount RSUs Value per share, less discount for post vesting restrictions on sale Former senior executive officer responsible for overseeing the financial activities of the entity. Former Chief Financial Officer [Member] Thomas Hayes [Member] Four Key Executives Group One [Member] Four Key Executives Group One [Member] Four Key Executives Group Two [Member] Four Key Executives Group Two [Member] Agreed monthly payment amount for subleased space. Monthly Sublease Payment Amount Monthly sublease payment amount Document Period End Date Post Vesting Restrictions Discount Rate. PostVestingRestrictionsDiscountRate RSU, discount rate Term Of Options Granted Post Vesting Restrictions. TermOfOptionsGrantedPostVestingRestrictions Post-vesting restrictions, term Square footage for rent in an operating lease. Operating Lease, Square Footage Lease, square footage Award Type [Axis] Plan Name One Member. 2003 Plan [Member] Plan Name Two Member. 2007 NPDC Plan [Member] Share Based Compensation Arrangement By Share Based Payment Award Exercise Price Of Options Granted Percentage Of Fair Market Value. Sharebased Compensation Arrangement By Sharebased Payment Award Exercise Price Of Options Granted Percentage Of Fair Market Value Sharebased Compensation Arrangement By Sharebased Payment Award Expected Term For Certain Holders. SharebasedCompensationArrangementBySharebasedPaymentAwardExpectedTermForCertainHolders Term for options granted to a 10% or greater holder of total voting stock RSU issuance per share amount. RSUIssuancePerShareAmount RSUs value per share Two Newly Appointed Directors [Member] Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts receivable,net Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Weighted average useful life of intangible assets Additional paid-in capital [Member] Additional Paid in Capital, Common Stock Additional paid-in capital Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities: Adjustments to Additional Paid in Capital, Share-based Compensation and Exercise of Stock Options Equity based compensation expense Allocated Share-based Compensation Expense Equity based compensation Amortization of Intangible Assets Amortization expense related to intangible assets Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Total assets Total assets Assets [Abstract] Assets Assets, Current [Abstract] Current assets Assets, Current Total current assets Available-for-sale Securities, Gross Unrealized Gain Unrealized Gains Unrealized (losses) gains Business Acquisition [Axis] Business Combination, Contingent Consideration, Liability Fair value of contingent liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Change in liability for contigent consideration Change in liability for contigent consideration Business Acquisition, Percentage of Voting Interests Acquired Percentage of equity interests acquired Contingent Consideration [Abstract] Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issuance of common stock in connection with acquisition, shares Business Acquisition [Line Items] Business Combination Disclosure [Text Block] Contingent Consideration Counterparty Name [Axis] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at the end of the year Cash and cash equivalents at the beginning of the year Cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Net decrease in cash and cash equivalents Class of Warrant or Right, Number of Securities Called by Warrants or Rights Common Stock Purchase Warrant, amount of shares Class of Warrant or Right, Outstanding Warrants received Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Commitments and Contingencies Disclosure [Text Block] Contingencies and commitments Contingencies and commitments [Abstract] Common Stock [Member] Common Stock, Value, Issued Common stock Corporate [Member] Cost and Equity Method Investments Disclosure [Text Block] Investment in LLC Investment Management and Advisory Contracts [Member] Debt Instrument, Term Term of note Debt Instrument, Face Amount Principal amount Debt Instrument, Interest Rate, Stated Percentage Interest rate Deferred Compensation Arrangement with Individual, Recorded Liability Total obligation Deferred Revenue Deferred revenue Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Discount rate Defined Contribution Plan, Employer Matching Contribution, Percent Employer match percentage Defined Benefit Plan, Expected Future Benefit Payments, Remainder of Fiscal Year Obligation payable in next 12 months Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Employer match of eligible compensation of employees Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation Liability recorded at date of acquisition Defined Benefit Plan, Benefit Obligation Present value of plan Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Defined Contribution Plan, Cost Recognized Contribution costs Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Depreciation, Depletion and Amortization Depreciation and amortization Depreciation and amortization Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Incentive stock plans and stock based compensation Incentive stock plans and stock based compensation [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Earnings Per Share, Basic and Diluted Basic and diluted net loss per share Earnings Per Share [Text Block] Per share data Per share data [Abstract] Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized compensation recognition period Employee Stock Option [Member] Stock Options [Member] Options [Member] Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Unrecognized compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation cost Equity Component [Domain] Equity Method Investment, Ownership Percentage Equity investment, percentage Membership Interest Equity Method Investments Investment in LLC Equity investment Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Decrease in value of warrant Change in value of warrant Fair Value Inputs, Discount Rate Present value discount factor Fair Value Assumptions, Expected Volatility Rate Expected volatility Financial Instruments, Owned, Other, at Fair Value Warrant distributed from LLC Financial Services Revenue [Abstract] Revenues Finite-Lived Intangible Assets, Amortization Expense, after Year Five 2021-2023 Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Amortization Expense, Year Two 2017 Finite-Lived Intangible Assets, Net Net carrying amount Finite-lived intangible assets, net carrying amount Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2016 Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Gross Gross carrying amount Finite-Lived Intangible Asset, Useful Life Estimated useful life Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2016 (remainder) Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Amortization Expense, Year Five 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2018 Gain (Loss) on Sale of Equity Investments Gain on sale of investment in MXL Gain on sale of investment in MXL Corporate Goodwill Goodwill Income taxes [Abstract] Income (Loss) from Continuing Operations Attributable to Parent Loss from continuing operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Income from discontinued operations, net of taxes Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Share of income from equity method investments Equity in income of LLC Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss from before income taxes Loss before income taxes Income Tax Disclosure [Text Block] Income taxes Income Tax Expense (Benefit) Income tax expense Income Statement [Abstract] Income Taxes Receivable, Current Prepaid income taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Minimum state taxes Income Taxes Paid Income taxes Increase (Decrease) in Accounts Receivable Accounts receivables Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Asset Retirement Obligations Officers retirement bonus liability Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Income Taxes Receivable Prepaid income tax Increase (Decrease) in Operating Capital [Abstract] Changes in other operating items: Increase (Decrease) in Trading Securities Short-term investments Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Intangible Assets Disclosure [Text Block] Intangible Assets Intangible Assets [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Interest Expense, Other Interest expense Investment Advisory, Management and Administrative Fees Investment management and distribution fees Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Short-term investments Investment in LLC [Abstract] Short-term investments [Abstract] Lessee Leasing Arrangements, Operating Leases, Term of Contract Lease term Labor and Related Expense Compensation and benefits Lease Agreements [Member] Sublease arrangement [Member] Liabilities Total liabilities Liabilities and Equity Total liabilities and stockholders' equity Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current liabilities Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments Realized loss on sale of short-term investments Maximum [Member] Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling interest, ownership percentage Stockholders' Equity Attributable to Noncontrolling Interest Noncontrolling interest Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash used in financing activities Cash flows from financing activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Net Income (Loss) Attributable to Parent Net loss Net loss Non-operating income (expense): Number of operating segments Operating Leases, Future Minimum Payments Due Future minimum payments Operating Expenses [Abstract] Expenses Operating Leases, Future Minimum Payments, Remainder of Fiscal Year Future minimum payments remainder of 2016 Operating Leases, Future Minimum Payments, Due in Two Years Future minimum payments 2017 Operating Expenses Operating expenses Total expenses Operating Costs and Expenses [Abstract] Other operating expenses: Operating Leases, Future Minimum Payments, Due in Three Years Future minimum payments 2018 Operating loss Operating loss Operating Leases, Future Minimum Payments, Due in Four Years Future minimum payments 2019 Operating Leases, Future Minimum Payments, Due in Five Years Future minimum payments 2020 Basis of presentation and description of activities [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of presentation and description of activities Proprietary Software and Technology [Member] Amortization of stay and retention bonuses Other Assets, Noncurrent Other assets Other Cost and Expense, Operating Other operating Other Nonoperating Income (Expense) Interest expense and other income (loss), net Other Liabilities, Current Liability for contingent consideration Other Revenue, Net Financial research and related data Other Postretirement Defined Benefit Plan, Liabilities, Noncurrent Officers retirement bonus liability, net of current portion Payments to Acquire Businesses, Gross Cash paid Payments to Acquire Equity Method Investments Investment amount Investment in LLC Payments for Repurchase of Other Equity Repurchase of fully vested restricted stock units Payments to Acquire Property, Plant, and Equipment Additions to property and equipment Pension and Other Postretirement Benefits Disclosure [Text Block] Retirement plans Pension Plans, Defined Benefit [Member] Frozen defined benefit plans [Member] Retirement plans [Abstract] Plan Name [Domain] Plan Name [Axis] Postemployment Benefits Liability, Current Current portion of officers retirement bonus liability Preferred Stock, Value, Issued Preferred stock, par value $0.01 per share, authorized 10,000,000 shares; none issued Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prior Period Reclassification Adjustment Reclassification of Compensation and benefits to Other operating expenses Payment of liability for contingent consideration Proceeds from Sale and Maturity of Marketable Securities Proceeds from sale of short-term investments Proceeds from Sale of Equity Method Investments Proceeds from sale of investment in MXL Property, Plant and Equipment, Net Property and equipment, net Property and Equipment, Net, Total Range [Axis] Range [Domain] Related Party Transactions Disclosure [Text Block] Related party transactions Related Party [Domain] Related Party Transaction [Line Items] Related Party [Axis] Related party transactions [Abstract] Restricted Stock Units (RSUs) [Member] Restricted Stock or Unit Expense Compensation Restructuring Charges Relocation and severance costs Accumulated deficit [Member] Accumulated deficit [Member] Retained Earnings (Accumulated Deficit) Accumulated deficit Revenue, Other Financial Services Other investment advisory services Revenues Total revenues Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding options, weighted average contractual term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Term of any option granted under the plans Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Amortization Expense Related to Intangible Assets Sales Revenue, Services, Net Investment management services Schedule of Finite-Lived Intangible Assets [Table] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Fair Value Assumptions Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Finite-Lived Intangible Assets [Table Text Block] Components of Acquired Intangible Assets Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Investment, Name [Axis] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Information Schedule of Related Party Transactions, by Related Party [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Disclosure [Text Block] Segment Information Segments [Domain] Segment Information [Abstract] Segment Reporting [Abstract] Segment Reporting Information [Line Items] Share-based Compensation Equity based compensation, including issuance of stock to directors Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period for plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted - Stock Options Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number RSUs outstanding Share Price Stock price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period RSUs, Granted Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Common stock reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Number of shares reserved and available for award Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding options, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding options, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average fair value of stock options granted Shares, Issued Balance, shares Balance, shares Short-term Investments Short-term investments Short-term Debt, Type [Axis] Statement [Line Items] Statement, Equity Components [Axis] CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Abstract] Statement of Cash Flows [Abstract] Statement [Table] Statement of Financial Position [Abstract] Segments [Axis] Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Issuance of common stock to directors, shares Stock Repurchase Program, Number of Shares Authorized to be Repurchased Number of shares authorized to be repurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Remaining number of shares available for repurchase Number of shares repurchased during period RSUs repurchased during period, shares Stock or Unit Option Plan Expense Compensation expense related to option grants Stock Compensation Plan [Member] Common stock [Member] Value of shares repurchased during period RSUs repurchased during period Stock issued for RSUs, shares Shares issuable for vested restricted stock units, shares Issued restricted stock, shares Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Issuance of common stock to directors Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity Stockholders' Equity Note Disclosure [Text Block] Capital Stock Capital Stock [Abstract] Stockholders' Equity Attributable to Parent Balance Balance Total stockholders' equity Subsequent Event [Member] Subsequent Event Type [Axis] Subsidiaries [Member] Winthrop [Member] Supplemental Cash Flow Information [Abstract] Supplemental disclosures of cash flow information Title of Individual [Axis] Trademarks [Member] Treasury stock, at cost [Member] Treasury Stock, Shares Treasury stock, shares Treasury Stock, Number of Shares Held Number of shares repurchased Treasury Stock, Value Treasury stock, at cost (565,219 common shares at March 31, 2016 and December 31, 2015) Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average number of common shares outstanding Weighted Average Number of Shares, Restricted Stock Weighted average number of common shares, vested RSUs EX-101.PRE 10 wish-20160331_pre.xml EXHIBIT 101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2016
May. 11, 2016
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2016  
Entity Registrant Name Wright Investors Service Holdings, Inc.  
Entity Central Index Key 0001279715  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2016  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   18,919,573
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues    
Investment management services $ 588 $ 623
Other investment advisory services 714 697
Financial research and related data 175 158
Total revenues 1,477 1,478
Expenses    
Compensation and benefits 1,092 1,295
Other operating 904 1,082
Total expenses 1,996 2,377
Operating loss (519) (899)
Interest expense and other income (loss), net $ 28 (37)
Change in fair value of contingent consideration 112
Loss before income taxes $ (491) (824)
Income tax expense 16 17
Net loss $ (507) $ (841)
Basic and diluted net loss per share $ (0.03) $ (0.04)
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 8,227 $ 8,493
Short-term investments 157
Accounts receivable,net $ 359 326
Prepaid income taxes 8 37
Prepaid expenses and other current assets 373 456
Total current assets 8,967 9,469
Property and equipment, net 44 44
Intangible assets, net 2,485 2,644
Goodwill 3,364 3,364
Investment in LLC 321 287
Investment in undeveloped land 355 355
Other assets 122 120
Total assets 15,658 16,283
Current liabilities    
Accounts payable and accrued expenses 874 $ 1,030
Deferred revenue 14
Current portion of officers retirement bonus liability 200 $ 200
Total current liabilities 1,088 1,230
Officers retirement bonus liability, net of current portion 684 714
Total liabilities 1,772 1,944
Stockholders' equity    
Common stock 197 197
Additional paid-in capital 33,542 33,488
Accumulated deficit (18,494) (17,987)
Treasury stock, at cost (565,219 common shares at March 31, 2016 and December 31, 2015) (1,359) (1,359)
Total stockholders' equity 13,886 14,339
Total liabilities and stockholders' equity $ 15,658 $ 16,283
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED BALANCE SHEETS (Parenthetical) - shares
Mar. 31, 2016
Dec. 31, 2015
Statement of Financial Position [Abstract]    
Treasury stock, shares 565,219 565,219
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities    
Net loss $ (507) $ (841)
Adjustments to reconcile net loss to cash used in operating activities:    
Realized loss on sale of short-term investments 9
Depreciation and amortization $ 163 $ 164
Change in liability for contigent consideration $ (112)
Decrease in value of warrant $ (2)
Equity based compensation, including issuance of stock to directors 54 $ 72
Equity in income of LLC (34)
Changes in other operating items:    
Accounts receivables $ (33) $ (102)
Short-term investments (3)
Deferred revenue $ 14 1
Officers retirement bonus liability (30) 19
Prepaid income tax 29 4
Prepaid expenses and other current assets 83 122
Accounts payable and accrued expenses (156) 72
Net cash used in operating activities (410) $ (604)
Cash flows from investing activities    
Proceeds from sale of short-term investments 148
Additions to property and equipment (4) $ (9)
Net cash provided by (used in) investing activities 144 (9)
Cash flows from financing activities    
Net decrease in cash and cash equivalents (266) (613)
Cash and cash equivalents at the beginning of the year 8,493 11,163
Cash and cash equivalents at the end of the year $ 8,227 10,550
Net cash paid during the period for    
Income taxes $ 10
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2016 - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional paid-in capital [Member]
Accumulated deficit [Member]
Treasury stock, at cost [Member]
Balance at Dec. 31, 2015 $ 14,339 $ 197 $ 33,488 $ (17,987) $ (1,359)
Balance, shares at Dec. 31, 2015   19,720,971      
Net loss (507)   $ (507)
Equity based compensation expense 27 27
Issuance of common stock to directors 27 27
Issuance of common stock to directors, shares   13,821      
Balance at Mar. 31, 2016 $ 13,886 $ 197 $ 33,542 $ (18,494) $ (1,359)
Balance, shares at Mar. 31, 2016   19,734,792      
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Basis of presentation and description of activities
3 Months Ended
Mar. 31, 2016
Basis of presentation and description of activities [Abstract]  
Basis of presentation and description of activities
1.
Basis of presentation and description of activities
 
 Basis of presentation
 
The accompanying interim financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  The information and note disclosures normally included in complete financial statements have been condensed or omitted pursuant to such rules and regulations.  The Condensed Consolidated Balance Sheet as of December 31, 2015 has been derived from audited financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2015 as presented in our Annual Report on Form 10-K. In the opinion of management, this interim information includes all material adjustments, which are of a normal and recurring nature, necessary for a fair presentation. The results for the 2016 interim period are not necessarily indicative of results to be expected for the entire year.

 Description of activities
 
On December 19, 2012 (the “Closing Date”), National Patent Development Corporation, which changed its name on February 4, 2013 to Wright Investors' Service Holdings, Inc. (hereinafter referred to as the “Company” or “Wright Holdings”), completed the acquisition of The Winthrop Corporation, a Connecticut corporation (“Winthrop”) pursuant to that certain  Agreement and Plan of Merger (the “Merger Agreement”) dated June 18, 2012. Winthrop, through its wholly-owned subsidiaries Wright Investors' Service, Inc. (“Wright”), Wright Investors' Service Distributors, Inc. (“WISDI”) and Wright's wholly-owned subsidiary, Wright Private Asset Management, LLC (“WPAM”) (collectively, the “Wright Companies”), offers investment management services,  financial advisory services and investment research to large and small investors, both taxable and tax exempt.  WISDI is a registered broker dealer with the Financial Industry Regulatory Authority, Inc. (“FINRA”) and the Securities and Exchange Commission.  In accordance with the Merger Agreement, a wholly-owned newly formed subsidiary of the Company, was merged with and into Winthrop and Winthrop became a wholly-owned subsidiary of the Company.

Critical accounting policies and estimates
 
There have been no changes to our critical accounting policies and estimates in the three months ended March 31, 2016. The Securities and Exchange Commission (“SEC”) defines “critical accounting policies” as those that require application of management's most difficult subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Our significant accounting policies are described under “Critical Accounting Policies” in our “Management's Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7, as well as in our consolidated financial statements and footnotes thereto for the year ended December 31, 2015, as filed with the Commission with our Annual Report form 10-K filed on March 23, 2016.

Reclassification

The Company has reclassified $11,000 of Compensation and benefits for the period ended March 31, 2015 to Other operating expenses in order to be consistent with the presentation for the period ended March 31, 2016.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingent Consideration
3 Months Ended
Mar. 31, 2016
Contingent Consideration [Abstract]  
Contingent Consideration
2.
Contingent Consideration

In connection with the Company's acquisition of Winthrop on December 19, 2012, the Company had agreed to pay contingent consideration in cash to a holder of Winthrop common stock who received 852,228 shares of Company Common Stock to the extent that such shares have a value of less than $1,900,000 on the expiration of the three year period based on the average closing price of the Company's Common Stock for the ten trading days prior to such date.  A liability was recognized for an estimate of the acquisition date fair value of the acquisition-related contingent consideration which may be paid.   Changes in the fair value of the contingent consideration subsequent to the acquisition date were recognized in earnings until the liability was eliminated or settled. In December 2015, the Company paid $236,000 to settle the contingent consideration liability and recognized income of $336,000 for the reduction in the fair value of the liability during the year ended December 31, 2015. The Company recognized income of $112,000 for the change in the fair value of the liability for the three months ended March 31, 2015.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per share data
3 Months Ended
Mar. 31, 2016
Per share data [Abstract]  
Per share data
3. 
Per share data

Loss per share for the three months ended March 31, 2016 and 2015, respectively, is calculated based on 19,198,000 and 19,229,000 weighted average outstanding shares of common stock.  Included in these shares are vested RSUs of 35,706 and 608,526 for the quarters ended March 31, 2016 and 2015, respectively.

Options for 3,375,000 shares of common stock for the three months ended March 31, 2016 and 2015, and unvested RSUs for 133,332 and 332,923 shares of common stock, respectively, for the three months  ended March 31, 2016 and 2015 were not included in the diluted computation as their effect would be anti-dilutive since the Company incurred net losses for both periods.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Capital Stock
3 Months Ended
Mar. 31, 2016
Capital Stock [Abstract]  
Capital Stock
4. 
Capital Stock 
 
The Company's Board of Directors, without any vote or action by the holders of common stock, is authorized to issue preferred stock from time to time in one or more series and to determine the number of shares and to fix the powers, designations, preferences and relative, participating, optional or other special rights of any series of preferred stock.
 
The Board of Directors authorized the Company to repurchase up to 5,000,000 outstanding shares of common stock from time to time either in open market or privately negotiated transactions. At March 31, 2016, the Company had repurchased 1,791,971 shares of its common stock and a total of 3,208,029 shares, remained available for repurchase at March 31, 2016.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
Short-term investments
3 Months Ended
Mar. 31, 2016
Short-term investments [Abstract]  
Short-term investments
5.
Short-term investments

Short-term investments, which at December 31, 2015 consisted of mutual funds managed by a subsidiary of Winthrop are stated at the net asset value of the funds and are accounted for as trading securities with unrealized gain or loss included in Interest expense and other income (loss), net in the Condensed Consolidated Statements of Operations.  The Company liquidated these investments in the first quarter of 2016 for proceeds of $148,000 and realized a loss of $9,000.   Unrealized  gains on short term investments amounted to $3,000 during the three months ended March 31, 2015.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Investment in LLC
3 Months Ended
Mar. 31, 2016
Investment in LLC [Abstract]  
Investment in LLC
6.
Investment in LLC

The Company entered into a Limited Liability Company Agreement dated April 28, 2015 by and among EGS, LLC,  a newly formed Delaware limited liability company (“EGS”) and the members named therein.  The Company invested $333,333 and acquired 333,333 Units, representing a 33.33% Membership Interest in EGS. In addition to the Company, EGS has two other members, one of whom is Marshall Geller, a member of the Company's Board of Directors. The EGS transaction, as well as Mr. Geller's participation in the transaction, received the prior approval of the Company's Audit Committee.  Mr. Geller is the Managing Member of the LLC and also invested $333,333 and acquired 333,333 Units, representing a 33.33% Membership Interest in EGS.
 
EGS entered into a Note Purchase Agreement effective April 28, 2015 with Merriman Holdings, Inc. (“Merriman”), a publically traded company,  pursuant to which EGS purchased from Merriman for an aggregate purchase price of $1,000,000  (i) a one-year  Senior Secured Note in the original principal amount of $1,000,000, at 12% interest, payable quarterly, in arrears (the “Note”) and (ii) a Common Stock Purchase Warrant which expires in five years to purchase 500,000 shares of Merriman common stock  at $1.00 per share (the “Warrants”).   EGS distributed the Warrants to its members and the Company received 166,666 Warrants which expire in five years.  On July 20, 2015, a fourth member joined EGS and invested $333,333, and received a 25% Membership Interest in EGS.  EGS advanced the funds to Merriman and increased its investment in the Note and in addition, received 166,666 additional Warrants which it distributed to its new member.  This transaction reduced the Company's interest in EGS to 25%, changed the expiration date of the Note to July 20, 2016, and extended the exercise date of the warrant to five years from that date. The investment in EGS is being accounted for under the equity method. Under this method, the Company records its share of EGS's earnings (losses) in the statement of operations with equivalent amount of increases (decreases) to the investment. The Company recorded approximately $34,000 as its share of EGS's net income for the quarter ended March 31, 2016, which is included in Interest expense and other income (loss), net.  At April 28, 2015, the Company valued the Warrants at their fair value, of $120,000, using the Black Scholes model, and recorded their value as a reduction in the investment in EGS.   At March 31, 2016 and December 31, 2015, the carrying value of the investment in EGS was $321,000 and $287,000, respectively. The Warrant which permits a cashless exercise, qualifies as a derivative, and is recorded at fair value (based on observable inputs) with change in such value included in earnings.   At March 31, 2016 and December 31, 2015, the value of the Warrant (a Level 2 Security) was $14,000 and $12,000, respectively, which is included in Other Assets in the Consolidated Balance Sheet.  The increase in the value of the Warrant of $2,000  for the quarter ended March 31, 2016 is included in Interest expense and other income (loss), net in the Consolidated Statement of Operations.  Such increase reflects the increase in the price of Merriman's common stock as measured for the three months ended March 31, 2016.

Merriman is a financial services holding company that provides capital markets advisory and research, corporate and investment banking services through its wholly-owned principal operating subsidiary, Merriman Capital, Inc. (“MC”).  The Note is secured by 99.998% of the capital stock of MC.  Marshall Geller also received 166,666 Warrants with an exercise price of $1.00 per share that expire in five years.
 
The Note, pursuant to the terms of an Intercreditor Agreement entered into with Merriman's current debt holders, is senior to all of Merriman's debt.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Incentive stock plans and stock based compensation
3 Months Ended
Mar. 31, 2016
Incentive stock plans and stock based compensation [Abstract]  
Incentive stock plans and stock based compensation
7.
Incentive stock plans and stock based compensation
 
Common stock options

The Company had initially adopted a stock-based compensation plan for employees and non-employee members of its Board of Directors in November 2003 (the “2003 Plan”), which was subsequently amended in March 2007 (the “2003 Plan Amendment”).  In December 2007, the Company adopted the National Patent Development Corporation 2007 Incentive Stock Plan (the “2007 NPDC Plan”).  The plans provide for up to 3,500,000 and 7,500,000 awards for shares under the 2003 Plan Amendment and 2007 NPDC Plan, respectively, in the form of discretionary grants of stock options, restricted stock shares, restricted stock units (RSUs) and other stock-based awards to employees, directors and outside service providers. The Company's plans are administered by the Compensation Committee of the Board of Directors, which consists solely of non-employee directors. The term of any option granted under the plans will not exceed ten years from the date of grant and, in the case of incentive stock options granted to a 10% or greater holder of total voting stock of the Company, three years from the date of grant.  The exercise price of any option granted under the plans may not be less than the fair market value of the common stock on the date of grant or, in the case of incentive stock options granted to a 10% or greater holder of total voting stock, 110% of such fair market value.

The Company recorded no compensation expense related to option grants for the three months ended March 31, 2016 and 2015, respectively. As of March 31, 2016, the number of shares reserved and available for award under the 2007 NPDC Plan is 6,116,786 and under the 2003 Plan Amendment is 700,000.

During the three months ended March 31, 2016, the Company issued 100,000 options to a consultant on March 28, 2016 and 25,000 options to an employee on March 31, 2016.  The options issued on March 28, 2016 vest equally over 3 years, and are subject to post vesting restrictions for sale for three years. The options issued on March 31, 2016 vest on the third anniversary of their issuance.  The options were issued at an exercise price of $1.29 and $1.34 per share for the options issued on March 28, 2016 and March 31, 2016, respectively, equal to market value at the date of the grant.  The grant-date fair value of the options were $0.50 and $0.52, respectively, which was estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions:
 
 
Dividend yield
   
0
%
Expected volatility
   
48.24
%
Risk-free interest rate
   
1.21
%
Expected life (in years)
   
4
 

 
The fair value of the options granted on March 28, 2016 were reduced by an 8% discount.

During the three months ended March 31, 2015, there was no option activity.  As of March 31, 2016, there were outstanding options to acquire 3,375,000 common shares, 3,250,000 of which were vested and exercisable, having a weighted average exercise price of $2.27 per share, a weighted average contractual term of 1.7 years and an aggregate intrinsic value of $5,000.

As of March 31, 2016, the unrecognized compensation expense related to non-vested options was $59,000


Restricted stock units

As a result of the Winthrop acquisition, the Company issued a total of 849,280 RSUs on the closing date to be settled in shares of Company common stock as follows:

 
a)
479,280 RSUs were granted to four key executives of Winthrop, which vested as of the Closing Date and are subject to post-vesting restrictions on sale for three years.  The RSUs were valued at the closing price of the Company's common stock of $2.52, less a 20% discount for post vesting restrictions on sale, or $2.02 per share.  The total value of these RSUs of $966,000, were accounted for as compensation and charged to retention bonus expense on the closing date.
 
 
b)
370,000 RSUs were granted to four key executives, which vest  equally over three years, with the first third vesting one year from the Closing Date.  The RSUs were valued based on the closing price of the Company's common stock on the Closing Date of $2.52, less an average discount of 11% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $2.25. The Company recorded compensation expense of $69,000 for the quarter ended March 31, 2015 related to these RSUs.

 
At December 19, 2015, the above RSUs were fully vested.    In December 2015, the Company repurchased 252,767 RSUs for a total cost of $369,000.  The remaining 596,513 RSUs were settled by the issuance of 596,513 common shares in the first quarter of 2016. Such issuable shares are included in the outstanding common shares at December 31, 2015 in the accompanying financial statements.


In addition, the following RSUs were granted to employees of the Company:
 
 
(c)
17,738 RSUs were granted to certain employees on February 4, 2013, which vest equally over three years, with the first third vesting on February 4, 2014.  At March 31, 2016, 11,701 of the RSU's were fully vested.  The RSUs are valued based on the closing price of the Company's common stock on February 4, 2013 of $2.40, less an average discount of 11% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $2.25.  The Company recorded compensation expense of $1,000 and $3,000, respectively, for the quarters ended March 31, 2016 and 2015 related to these RSUs.   There was no unrecognized compensation expense related to these unvested RSUs at March 31, 2016.

 
d)
30,000 RSUs were granted to an employee on June 10, 2014, which will vest on the third anniversary of the individual's employment, assuming the individual is still employed at that time.   The RSUs are valued based on the closing price of the Company's common stock on June 10, 2014 of $1.90.   For the quarter ended March 31, 2015,  $11,000 of compensation expense previously recorded during the year ended December 31, 2014 related to these RSUs was reversed since in the first quarter of 2015, the individual was no longer employed by the Company and the above RSUs were cancelled. 
 
 
e)
On January 19, 2015 and March 31, 2015, 100,000 RSUs were issued on each date to two newly appointed directors of the Company.  The RSUs will vest equally over 3 years.  The RSUs are valued based on the closing price of the Company's common stock on January 19, 2015 and March 31, 2015 of $1.70 and $1.85, respectively, less an average discount of 8% for post-vesting restrictions on sale until the three year anniversary of the grant date, or an average price per share of $1.56 and $1.70, respectively.  The Company recorded compensation expense of $26,000 and $11,000 for the quarters ended March 31, 2016 and 2015, respectively,  related to these RSUs.  The total unrecognized compensation expense related to these unvested RSUs at March 31, 2016 is $205,000, which will be recognized over the remaining vesting period of approximately 2 years.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets
3 Months Ended
Mar. 31, 2016
Intangible Assets [Abstract]  
Intangible Assets
8. 
Intangible Assets
 
At March 31, 2016, intangible assets subject to amortization which were recorded in connection with the acquisition of Winthrop consisted of the following (in thousands):


 
Intangible
Estimated
useful life
 
Gross
carrying
amount
   
Accumulated
Amortization
   
Net
carrying
amount
 
                     
Investment management and Advisory Contracts
  9 years
 
$
3,181
   
$
1,159
   
$
2,022
 
Trademarks
   10 years
   
433
     
142
     
291
 
Proprietary software and
technology
   
4 years
   
  960
     
788
     
  172
 
     
$
4,574
   
$
2,089
   
$
2,485
 


For the three month periods ended March 31, 2016 and 2015, amortization expense was $159,000 and $160,000, respectively. The weighted-average amortization period for total amortizable intangibles at March 31, 2016 is 4.75 years.  Estimated amortization expense for each of the five succeeding years and thereafter is as follows (in thousands):


Year ending December 31,
 
 
2016 (remainder)
 
$470
2017
 
  397
2018
 
  397
2019
 
  397
2020
 
  397
2021-2023
  427
 
 
$2,485
 
 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Related party transactions
3 Months Ended
Mar. 31, 2016
Related party transactions [Abstract]  
Related party transactions
9. 
Related party transactions
 
Effective June 1, 2010, the Company relocated its headquarters to the offices of Bedford Oak in Mount Kisco, New York. Bedford Oak is controlled by Harvey P. Eisen, Chairman, Chief Executive Officer and a director of the Company. The Company has been subleasing a portion of the Bedford Oak space and has access to various administrative support services on a month-to-month basis.  On October 31, 2012, the Company's Audit Committee approved an increase to approximately $40,700 per month (effective as of September 1, 2012) in the monthly sublease and administrative support services rate, which increased rate the Company believed, was necessary to provide for the increased personnel and space requirements necessary for an operating company.   

On May 13, 2014, the Company's Audit Committee approved a decrease to approximately $27,600 per month (effective as of June 1, 2014) in the monthly sublease and administrative support services rate, which decreased rate is part of the Company's effort to control and reduce costs.  Operating expenses for the quarters ended March 31, 2015 includes $83,000 related to the sublease arrangement with Bedford Oak. See Note 12 (a) for a description and the terms of the Company's sublease transaction for its new corporate headquarters.  In March 2015, the Audit Committee approved the elimination of the monthly sublease and administrative support services fee effective March 31, 2015 as a result of the Company's relocation to its new corporate headquarters.
 
Wright acts as an investment advisor, its subsidiary acts as a principal underwriter and one officer of Winthrop is also an officer for a family of mutual funds from which investment management and distribution fees are earned based on the net asset values of the respective funds.  Such fees, which are included in Other investment advisory services, amounted to $206,000 and $209,000 for the quarters ended March 31, 2016 and 2015, respectively.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.4.0.3
Income taxes
3 Months Ended
Mar. 31, 2016
Income taxes [Abstract]  
Income taxes
10. 
Income taxes

For the three months ended March 31, 2016 and 2015,  income tax expense  of $16,000 and $17,000, respectively,  represents minimum state taxes. No tax benefit has been recorded in relation to the pre-tax loss for the three months ended March 31, 2016 and 2015, due to the Company providing a full valuation allowance to offset any deferred tax asset related to net operating loss carry forwards attributable to the losses.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
Retirement plans
3 Months Ended
Mar. 31, 2016
Retirement plans [Abstract]  
Retirement plans
11. 
Retirement plans
 

 
a)
The Company maintains a 401(k) Savings Plan (the “Plan”), for full time employees who have completed at least one hour of service coincident with the first day of each month.  The Plan permits pre-tax contributions by participants.   Effective January 15, 2013, the employees of Winthrop and its subsidiaries were eligible to participate in the Plan, and the Company ceased matching the participants contributions.

 
b)
Winthrop maintains an officer retirement bonus plan (the “Bonus Plan”) that is an unfunded deferred compensation program providing retirement benefits equal to 10% of annual compensation, as defined, to those officers upon their retirement.   Effective December 1, 1999, the Plan was frozen so that no additional benefits will be earned.  The present value of the obligation under the Bonus Plan at March 31, 2016, is $884,000, of which $200,000 is estimated to be payable over the next twelve months.  The liability is payable to individual retired employees at the rate of $50,000 per year in equal monthly amounts commencing upon retirement.  The liability was recorded at $885,000 at the date of acquisition, representing its estimated fair value computed based on its present value, utilizing a discount rate of 14%, which was estimated to be the acquired company's weighted average cost of capital on such date from the perspective of a market participant.  The calculated discount of $1,027,000 at the date of acquisition is being amortized as interest expense over the period the obligation is outstanding by use of the effective interest method.  For the three months ended March 31, 2016 and 2015, interest expense, included in Interest expense and other income (loss), net amounted to $20,000 and $37,000, respectively. At March 31, 2016, the present value of the obligation under the Bonus Plan was $884,000, net of discount of $586,000.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingencies and commitments
3 Months Ended
Mar. 31, 2016
Contingencies and commitments [Abstract]  
Contingencies and commitments
12. 
Contingencies and commitments
 


(a)
On July 1, 2014, Winthrop, pursuant to the terms of its Milford facility lease, gave eight months' notice to their landlord to terminate their lease in Milford, Connecticut.  In August 2014, the Company entered into a five year sublease in Greenwich, Connecticut for 10,000 square feet.  At March 31, 2016, annual future rent for the Greenwich, Connecticut space, under the sublease which expires on September 30, 2019 aggregated $879,000 payable as follows; $180,000 (remaining in 2016), $248,000 (2017), $255,000 (2018), and $196,000 (through September 30, 2019).   The Company moved their corporate office from Mount Kisco, New York to the new Greenwich, Connecticut facility in March 2015, which resulted in a consolidation of the Company's operations.
 
(b)
On September 26, 2014, the Connecticut Department of Energy and Environmental Protection (“DEEP”) issued two Orders requiring the investigation and repair of two dams in which the Company and its subsidiaries have certain ownership interests.  The first Order requires that the Company investigate and make specified repairs to the ACME Pond Dam located in Killingly, Connecticut.  The second Order, as subsequently revised by DEEP on October 10, 2014, requires that the Company investigate and make specified repairs to the Killingly Pond Dam located in Killingly, Connecticut.  The Company has administratively appealed and contested the allegations in both Orders.  As the administrative appeal of both Orders is in its early stages, it is not possible at this time to evaluate the likelihood of, or to estimate the range of loss from, an unfavorable outcome.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Information
3 Months Ended
Mar. 31, 2016
Segment Information [Abstract]  
Segment Information
13.
Segment information


The Company through its wholly-owned subsidiaries has one operating segment which is engaged in the investment management and financial advisory business and which derives its revenue from investment management services, other investment advisory services and financial research.
 
The Company's corporate operations are not considered an operating segment and the Company does not allocate corporate expense for management and administrative services or income and expense related to other corporate activity to its operating segment to measure its operations.  The Company's management utilizes adjusted EBITDA to measure segment performance.  Adjusted EBITDA is a measure defined as EBITDA before corporate expense, equity based compensation, amortization of stay and retention bonuses, relocation and severance costs and non-operating income (expense).   EBITDA is a measure defined as earnings (loss) before interest, taxes, depreciation and amortization
 
Adjusted EBITDA is a non-GAAP measure and should not be construed as an alternative to operating loss or net loss as an indicator of the Company's performance, or as an alternative to cash used in operating activities, or as a measure of liquidity, or as any other measure determined in accordance with GAAP.

 
Following is a reconciliation of adjusted EBITDA of the operating segment to loss before income taxes (in thousands):
 

   
Three months ended March 31,
 
   
2016
   
2015
 
Adjusted EBITDA of operating segment
  $ 168     $ 18  
                 
Other operating expenses:
               
Corporate
    (398 )     (588 )
Depreciation and amortization
    (163 )     (164 )
Equity based compensation
    (54 )     (72 )
Amortization of stay and retention bonuses
    -       (37 )
Relocation and severance costs
    (72 )     (56 )
                 
Operating loss
    (519 )     (899 )
                 
Non- operating income (expense):
               
Interest expense and other (loss) income, net
    28       (37 )
Change in fair value of contingent consideration
    -       112  
                 
Loss from before income taxes
  $ (491 )   $ (824 )
                 
                 
Following is a summary of the Company's total
assets (in thousands):
               
   
March 31,
   
December 31,
 
    2016     2015  
Operating segment
  $ 6,747     $ 7,125  
Corporate (1)
    8,911       9,158  
    $ 15,658     $ 16,283  
 
(1) Consists principally of cash and cash equivalents
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
Incentive stock plans and stock based compensation (Tables)
3 Months Ended
Mar. 31, 2016
Incentive stock plans and stock based compensation [Abstract]  
Schedule of Fair Value Assumptions
Dividend yield
   
0
%
Expected volatility
   
48.24
%
Risk-free interest rate
   
1.21
%
Expected life (in years)
   
4
 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2016
Intangible Assets [Abstract]  
Components of Acquired Intangible Assets
Intangible
Estimated
useful life
 
Gross
carrying
amount
   
Accumulated
Amortization
   
Net
carrying
amount
 
                     
Investment management and Advisory Contracts
  9 years
 
$
3,181
   
$
1,159
   
$
2,022
 
Trademarks
   10 years
   
433
     
142
     
291
 
Proprietary software and
technology
   
4 years
   
  960
     
788
     
  172
 
     
$
4,574
   
$
2,089
   
$
2,485
 
Amortization Expense Related to Intangible Assets
Year ending December 31,
 
 
2016 (remainder)
 
$470
2017
 
  397
2018
 
  397
2019
 
  397
2020
 
  397
2021-2023
  427
 
 
$2,485
 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Information (Tables)
3 Months Ended
Mar. 31, 2016
Segment Information [Abstract]  
Schedule of Segment Information
   
Three months ended March 31,
 
   
2016
   
2015
 
Adjusted EBITDA of operating segment
  $ 168     $ 18  
                 
Other operating expenses:
               
Corporate
    (398 )     (588 )
Depreciation and amortization
    (163 )     (164 )
Equity based compensation
    (54 )     (72 )
Amortization of stay and retention bonuses
    -       (37 )
Relocation and severance costs
    (72 )     (56 )
                 
Operating loss
    (519 )     (899 )
                 
Non- operating income (expense):
               
Interest expense and other (loss) income, net
    28       (37 )
Change in fair value of contingent consideration
    -       112  
                 
Loss from before income taxes
  $ (491 )   $ (824 )
                 
                 
Following is a summary of the Company's total
assets (in thousands):
               
   
March 31,
   
December 31,
 
    2016     2015  
Operating segment
  $ 6,747     $ 7,125  
Corporate (1)
    8,911       9,158  
    $ 15,658     $ 16,283  
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.4.0.3
Basis of presentation and description of activities (Details)
3 Months Ended
Mar. 31, 2016
USD ($)
Basis of presentation and description of activities [Abstract]  
Reclassification of Compensation and benefits to Other operating expenses $ 11,000
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingent Consideration (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 19, 2012
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Business Acquisition [Line Items]        
Change in liability for contigent consideration   $ 112,000  
Winthrop [Member]        
Business Acquisition [Line Items]        
Issuance of common stock in connection with acquisition, shares 852,228      
Cash paid       $ 236,000
Contingent consideration, maximum value of shares $ 1,900,000      
Change in liability for contigent consideration     $ 112,000 $ 336,000
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per share data (Details) - shares
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Weighted average number of common shares outstanding 19,198,000 19,229,000
Weighted average number of common shares, vested RSUs 35,706 608,526
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3,375,000 3,375,000
Restricted Stock Units (RSUs) [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 133,332 332,923
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Capital Stock (Details)
Mar. 31, 2016
shares
Capital Stock [Abstract]  
Number of shares authorized to be repurchased 5,000,000
Number of shares repurchased 1,791,971
Remaining number of shares available for repurchase 3,208,029
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.4.0.3
Short-term investments (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Short-term investments [Abstract]    
Proceeds from sale of short-term investments $ 148,000
Realized loss on sale of short-term investments $ 9,000
Unrealized (losses) gains   $ 3,000
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Investment in LLC (Details) - USD ($)
1 Months Ended 3 Months Ended
Apr. 28, 2015
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Schedule of Equity Method Investments [Line Items]        
Equity investment   $ 321,000   $ 287,000
Change in value of warrant   (2,000)  
Exercise price of warrants $ 1.00      
Term of warrants 5 years      
Warrants received 166,666      
Share of income from equity method investments   $ 34,000  
EGS [Member]        
Schedule of Equity Method Investments [Line Items]        
Investment amount $ 333,333      
Units acquired 333,333      
Membership Interest 33.33% 25.00%    
Equity investment   $ 321,000   287,000
Share of income from equity method investments   34,000    
Marshall Geller [Member] | EGS [Member]        
Schedule of Equity Method Investments [Line Items]        
Investment amount $ 333,333      
Units acquired 333,333      
Membership Interest 33.33%      
Merriman Holdings, Inc. [Member]        
Schedule of Equity Method Investments [Line Items]        
Note Purchase Agreement, aggregate purchase price $ 1,000,000      
Term of note 1 year      
Principal amount $ 1,000,000      
Interest rate 12.00%      
Warrant distributed from LLC $ 120,000 14,000   $ 12,000
Change in value of warrant   $ 2,000    
Common Stock Purchase Warrant, amount of shares 500,000      
Term of warrants 5 years      
Merriman Holdings, Inc. [Member] | Marshall Geller [Member]        
Schedule of Equity Method Investments [Line Items]        
Exercise price of warrants $ 1.00      
Term of warrants 5 years      
Warrants received 166,666      
Merriman Capital, Inc. [Member]        
Schedule of Equity Method Investments [Line Items]        
Notes secured, percentage of capital stock   99.998%    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.4.0.3
Incentive stock plans and stock based compensation (Common Stock Options) (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2016
Mar. 28, 2016
Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options granted - Stock Options 25,000 100,000  
Unrecognized compensation cost $ 59,000   $ 59,000
Weighted average fair value of stock options granted $ 0.52 $ 0.50  
Term of any option granted under the plans     10 years
Term for options granted to a 10% or greater holder of total voting stock     3 years
Sharebased Compensation Arrangement By Sharebased Payment Award Exercise Price Of Options Granted Percentage Of Fair Market Value     110.00%
Outstanding options 3,375,000   3,375,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 3,250,000   3,250,000
Outstanding options, weighted average exercise price $ 2.27   $ 2.27
Outstanding options, weighted average contractual term     1 year 8 months 12 days
Outstanding options, aggregate intrinsic value $ 5,000   $ 5,000
Dividend yield     $ 0
Expected volatility     48.24%
Risk-free interest rate     1.21%
Expected life     10 years
Exercise price $ 1.34 $ 1.29  
2003 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock reserved for issuance 3,500,000   3,500,000
Number of shares reserved and available for award 700,000   700,000
2007 NPDC Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock reserved for issuance 7,500,000   7,500,000
Number of shares reserved and available for award 6,116,786   6,116,786
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.4.0.3
Incentive stock plans and stock based compensation (Restricted Stock) (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 10, 2014
Feb. 01, 2014
Jan. 19, 2015
Dec. 19, 2012
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted       849,280      
RSUs outstanding             596,513
RSUs repurchased during period             $ 369,000
RSUs repurchased during period, shares             252,767
Stock issued for RSUs, shares         596,513    
Two Newly Appointed Directors [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted     100,000     100,000  
Vesting period for plan     3 years     3 years  
RSUs value per share     $ 1.70     $ 1.85  
RSU, discount rate     8.00%     8.00%  
RSUs Value per share, less discount for post vesting restrictions on sale     $ 1.56     $ 1.70  
Compensation         $ 26,000 $ 11,000  
Unrecognized compensation cost         $ 205,000    
Unrecognized compensation recognition period         2 years    
Employees [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted   17,738          
Vesting period for plan   3 years          
RSUs value per share   $ 2.40          
RSU, discount rate   11.00%          
RSUs Value per share, less discount for post vesting restrictions on sale   $ 2.25          
Compensation         $ 1,000 $ 3,000  
Employee [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted 30,000            
RSUs value per share $ 1.90            
Compensation         $ 11,000    
Four Key Executives Group Two [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted       370,000      
Stock price       $ 2.52      
Vesting period for plan       3 years      
RSU, discount rate       11.00%      
RSUs Value per share, less discount for post vesting restrictions on sale       $ 2.25      
Compensation       $ 69,000      
Four Key Executives Group One [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
RSUs, Granted       479,280      
Stock price       $ 2.52      
Post-vesting restrictions, term       3 years      
RSU, discount rate       20.00%      
RSUs Value per share, less discount for post vesting restrictions on sale       $ 2.02      
Compensation       $ 966,000      
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Intangible Assets) (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2016
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Gross carrying amount $ 4,574
Accumulated Amortization 2,089
Net carrying amount $ 2,485
Investment Management and Advisory Contracts [Member]  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 9 years
Gross carrying amount $ 3,181
Accumulated Amortization 1,159
Net carrying amount $ 2,022
Trademarks [Member]  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 10 years
Gross carrying amount $ 433
Accumulated Amortization 142
Net carrying amount $ 291
Proprietary Software and Technology [Member]  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life 4 years
Gross carrying amount $ 960
Accumulated Amortization 788
Net carrying amount $ 172
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Estimated Amortization Expense) (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Intangible Assets [Abstract]    
2016 (remainder) $ 470,000  
2017 397,000  
2018 397,000  
2019 397,000  
2020 397,000  
2021-2023 427,000  
Finite-lived intangible assets, net carrying amount 2,485,000  
Amortization expense related to intangible assets $ 159,000 $ 160,000
Weighted average useful life of intangible assets 4 years 9 months  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.4.0.3
Related party transactions (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
May. 13, 2014
Oct. 31, 2012
Related Party Transaction [Line Items]        
Operating expenses $ 1,996,000 $ 2,377,000    
Bedford Oak [Member] | Sublease arrangement [Member]        
Related Party Transaction [Line Items]        
Monthly sublease payment amount     $ 27,600 $ 40,700
Operating expenses   83,000    
Winthrop [Member]        
Related Party Transaction [Line Items]        
Investment management and distribution fees $ 206,000 $ 209,000    
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.4.0.3
Income taxes (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Income taxes [Abstract]    
Minimum state taxes $ 16,000 $ 17,000
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
Retirement plans (Details) - Frozen defined benefit plans [Member] - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Defined Benefit Plan Disclosure [Line Items]    
Employer match of eligible compensation of employees 10.00%  
Total obligation $ 884,000  
Obligation payable in next 12 months 200,000  
Annual liability payable to individual retired employees 50,000  
Liability recorded at date of acquisition $ 885,000  
Present value discount factor 14.00%  
Amount to be amortized, as interest expense $ 1,027,000  
Interest expense 20,000 $ 37,000
Present value of plan 884,000  
Unamortized discount $ 586,000  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingencies and commitments (Details)
3 Months Ended
Mar. 31, 2016
USD ($)
Contingencies and commitments [Abstract]  
Lease term 5 years
Future minimum payments $ 879,000
Future minimum payments remainder of 2016 180,000
Future minimum payments 2017 248,000
Future minimum payments 2018 255,000
Future minimum payments 2019 $ 196,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2016
USD ($)
Mar. 31, 2015
USD ($)
Dec. 31, 2015
USD ($)
Segment Reporting Information [Line Items]      
Number of operating segments 1    
Other operating expenses:      
Depreciation and amortization $ (163) $ (164)  
Operating loss $ (519) (899)  
Non-operating income (expense):      
Change in fair value of contingent consideration 112  
Loss from before income taxes $ (491) (824)  
Total assets 15,658   $ 16,283
Operating Segment [Member]      
Segment Reporting Information [Line Items]      
Adjusted EBITDA (income/(loss)) of operating segment 168 18  
Other operating expenses:      
Corporate (398) (588)  
Depreciation and amortization (163) (164)  
Equity based compensation $ (54) (72)  
Amortization of stay and retention bonuses (37)  
Relocation and severance costs $ (72) (56)  
Operating loss (519) (899)  
Non-operating income (expense):      
Interest Expense, Other $ 28 (37)  
Change in fair value of contingent consideration 112  
Loss from before income taxes $ (491) $ (824)  
Total assets 6,747   7,125
Corporate [Member]      
Non-operating income (expense):      
Total assets [1] $ 8,911   $ 9,158
[1] Consists principally of cash and cash equivalents
EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 50 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 86 182 1 true 28 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.0001279715.com/role/wish-daei Document and Entity Information Cover 1 false false R2.htm 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.0001279715.com/role/Statement-CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 2 false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.0001279715.com/role/Statement-CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.0001279715.com/role/wish-cbsp1 CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.0001279715.com/role/Statement-CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.0001279715.com/role/wish-ccsocise CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 101 - Disclosure - Basis of presentation and description of activities Sheet http://www.0001279715.com/role/wish-bopadoa Basis of presentation and description of activities Notes 7 false false R8.htm 102 - Disclosure - Contingent Consideration Sheet http://www.0001279715.com/role/Disclosure-ContingentConsideration Contingent Consideration Notes 8 false false R9.htm 103 - Disclosure - Per share data Sheet http://www.0001279715.com/role/wish-psd Per share data Notes 9 false false R10.htm 104 - Disclosure - Capital Stock Sheet http://www.0001279715.com/role/wish-cs Capital Stock Notes 10 false false R11.htm 105 - Disclosure - Short-term investments Sheet http://www.0001279715.com/role/wish-stinv Short-term investments Notes 11 false false R12.htm 106 - Disclosure - Investment in LLC Sheet http://www.0001279715.com/role/InvestmentInLlc Investment in LLC Notes 12 false false R13.htm 107 - Disclosure - Incentive stock plans and stock based compensation Sheet http://www.0001279715.com/role/wish-ispasbc Incentive stock plans and stock based compensation Notes 13 false false R14.htm 108 - Disclosure - Intangible Assets Sheet http://www.0001279715.com/role/wish-ia1 Intangible Assets Notes 14 false false R15.htm 109 - Disclosure - Related party transactions Sheet http://www.0001279715.com/role/wish-rpt Related party transactions Notes 15 false false R16.htm 110 - Disclosure - Income taxes Sheet http://www.0001279715.com/role/wish-it Income taxes Notes 16 false false R17.htm 111 - Disclosure - Retirement plans Sheet http://www.0001279715.com/role/wish-rp Retirement plans Notes 17 false false R18.htm 112 - Disclosure - Contingencies and commitments Sheet http://www.0001279715.com/role/wish-cac Contingencies and commitments Notes 18 false false R19.htm 113 - Disclosure - Segment Information Sheet http://www.0001279715.com/role/SegmentInformation Segment Information Notes 19 false false R20.htm 307 - Disclosure - Incentive stock plans and stock based compensation (Tables) Sheet http://www.0001279715.com/role/wish-ispasbct Incentive stock plans and stock based compensation (Tables) Tables http://www.0001279715.com/role/wish-ispasbc 20 false false R21.htm 308 - Disclosure - Intangible Assets (Tables) Sheet http://www.0001279715.com/role/wish-iat1 Intangible Assets (Tables) Tables http://www.0001279715.com/role/wish-ia1 21 false false R22.htm 313 - Disclosure - Segment Information (Tables) Sheet http://www.0001279715.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.0001279715.com/role/SegmentInformation 22 false false R23.htm 40101 - Disclosure - Basis of presentation and description of activities (Details) Sheet http://www.0001279715.com/role/wish-bopadoad Basis of presentation and description of activities (Details) Details http://www.0001279715.com/role/wish-bopadoa 23 false false R24.htm 40201 - Disclosure - Contingent Consideration (Details) Sheet http://www.0001279715.com/role/Disclosure-ContingentConsiderationDetails Contingent Consideration (Details) Details http://www.0001279715.com/role/Disclosure-ContingentConsideration 24 false false R25.htm 40301 - Disclosure - Per share data (Details) Sheet http://www.0001279715.com/role/wish-psdd Per share data (Details) Details http://www.0001279715.com/role/wish-psd 25 false false R26.htm 40401 - Disclosure - Capital Stock (Details) Sheet http://www.0001279715.com/role/wish-csd Capital Stock (Details) Details http://www.0001279715.com/role/wish-cs 26 false false R27.htm 40501 - Disclosure - Short-term investments (Details) Sheet http://www.0001279715.com/role/wish-stinvd Short-term investments (Details) Details http://www.0001279715.com/role/wish-stinv 27 false false R28.htm 40601 - Disclosure - Investment in LLC (Details) Sheet http://www.0001279715.com/role/InvestmentInLlcDetails Investment in LLC (Details) Details http://www.0001279715.com/role/InvestmentInLlc 28 false false R29.htm 40701 - Disclosure - Incentive stock plans and stock based compensation (Common Stock Options) (Details) Sheet http://www.0001279715.com/role/Disclosure-IncentivestockplansandstockbasedcompensationCommonStockOptionsDetails Incentive stock plans and stock based compensation (Common Stock Options) (Details) Details http://www.0001279715.com/role/wish-ispasbct 29 false false R30.htm 40702 - Disclosure - Incentive stock plans and stock based compensation (Restricted Stock) (Details) Sheet http://www.0001279715.com/role/wish-ispasbcrsd Incentive stock plans and stock based compensation (Restricted Stock) (Details) Details http://www.0001279715.com/role/wish-ispasbct 30 false false R31.htm 40801 - Disclosure - Intangible Assets (Intangible Assets) (Details) Sheet http://www.0001279715.com/role/wish-iaiad1 Intangible Assets (Intangible Assets) (Details) Details http://www.0001279715.com/role/wish-iat1 31 false false R32.htm 40802 - Disclosure - Intangible Assets (Estimated Amortization Expense) (Details) Sheet http://www.0001279715.com/role/wish-iaeaed1 Intangible Assets (Estimated Amortization Expense) (Details) Details http://www.0001279715.com/role/wish-iat1 32 false false R33.htm 40901 - Disclosure - Related party transactions (Details) Sheet http://www.0001279715.com/role/wish-rptd Related party transactions (Details) Details http://www.0001279715.com/role/wish-rpt 33 false false R34.htm 41001 - Disclosure - Income taxes (Details) Sheet http://www.0001279715.com/role/wish-itd Income taxes (Details) Details http://www.0001279715.com/role/wish-it 34 false false R35.htm 41101 - Disclosure - Retirement plans (Details) Sheet http://www.0001279715.com/role/wish-rpd Retirement plans (Details) Details http://www.0001279715.com/role/wish-rp 35 false false R36.htm 41201 - Disclosure - Contingencies and commitments (Details) Sheet http://www.0001279715.com/role/wish-cacd Contingencies and commitments (Details) Details http://www.0001279715.com/role/wish-cac 36 false false R37.htm 41301 - Disclosure - Segment Information (Details) Sheet http://www.0001279715.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.0001279715.com/role/SegmentInformationTables 37 false false All Reports Book All Reports wish-20160331.xml wish-20160331.xsd wish-20160331_cal.xml wish-20160331_def.xml wish-20160331_lab.xml wish-20160331_pre.xml true true ZIP 54 0001214659-16-011450-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-16-011450-xbrl.zip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�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�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